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ABSTRACT
CONCEPTUALIZING THE PSYCHOSOCIAL ELEMENTS THAT SHOULD BE
ASSESSED IN CANDIDATES FOR HEMATOPOIETIC CELL TRANSPLANTATION:
SOCIAL WORKERS’ AND PSYCHOLOGISTS’ PERSPECTIVES
Jill Randall
April 7, 2021
Background: In the United States, approximately 23,000 hematopoietic cell
transplantations (HCT), also known as a bone marrow transplant, are performed annually.
Patients who undergo HCT are among the most acutely ill and medically vulnerable
oncology populations. Given the arduous nature of HCT, patients undergo an extensive
pre-transplant evaluation that typically includes psychosocial assessment. The literature
lacks a well-defined conceptual framework of the psychosocial elements that should be
assessed in HCT candidates. This has led to practice variation, which has in turn inhibited
high quality psychosocial research.

Method: Social workers and psychologists in HCT were recruited to participate in a
concept mapping study to elucidate the conceptual domain of psychosocial elements that
should be assessed in candidates pre-HCT. Concept mapping is a mixed methodology
that uses quantitative methods (multidimensional scaling and hierarchical cluster
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analysis) to analyze qualitative data. It results in a series of maps that depict the group’s
composite thinking about the conceptual domain.

Results: Participants brainstormed 114 distinct psychosocial elements and conceptualized
the elements into 12 distinct clusters: Transplant Mindset, Support System, Caregiver,
Lodging and Transportation, Financial and Legal, Work, Demographic Characteristics,
Mental Health, Communication, Education and Resource Needs, Physical Functioning,
and Cognition. Analyses of importance ratings showed that that participants who use
standardized psychosocial risk rating scales in their practice did not prioritize these
clusters differently than those who do not use risk rating scales in their practice.

Conclusion: Findings show that the domain of psychosocial elements is broad and multidimensional. The conceptualization converges with the literature in many respects but
also contains noteworthy divergences from the current literature. Divergences are of
particular interest since the perspectives of these psychosocial professionals have been
largely absent from the literature. The maps and findings may be used to inform the
development of a pre-HCT psychosocial assessment protocol that would constitute a high
quality practice standard and produce consistent data for psychosocial research.
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CHAPTER I: INTRODUCTION
Social workers have played a role in health care settings since the early 1900s
(National Association of Social Workers, 2016). They are the primary providers of
psychosocial interventions that aim to “optimize biomedical health care and to manage
the psychological/behavioral and social aspects of illness and its consequences so as to
promote better health” (Institute of Medicine, 2008, p. 9). To provide effective
interventions, social workers must first collect and assess data to help them understand
the patient and their situation. This is typically done by interviewing the patient and
reviewing collateral information such as the electronic health record. According to
Sheafor and Horejsi (2003), “When the assessment is complete, the social worker should
be able to describe the problem accurately and identify what needs to be changed to
improve the client’s situation.” (p. 244).
In short, social workers in health care provide psychosocial assessment and
intervention. The term, psychosocial, has only recently been defined by the National
Cancer Institute. The same report that touted the importance of psychosocial services in
cancer care also noted that no definition of psychosocial was found in the 2007 version of
the National Cancer Institute’s dictionary. Today, the National Cancer Institute’s
Dictionary provides the following definition for psychosocial:
In medicine, having to do with the mental, emotional, social, and spiritual effects
of a disease, such as cancer. Some of the psychosocial effects of cancer are
changes in how a patient thinks, their feelings, moods, beliefs, ways of coping,
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and relationships with family, friends, and co-workers. (National Cancer Institute,
2021).
In light of this broad definition, it is not surprising that, as Dew et al. (2000) state,
“The term [psychosocial] has been used to encompass virtually every nonsurgical or
nonmedical parameter of patients and their experiences.” (p. 240).
The literature lacks a well-defined conceptual framework of the psychosocial
elements that should be assessed in candidates for hematopoietic cell transplantation
(HCT), a subspeciality within oncology. This research uses concept mapping methods to
address this gap in the literature. This chapter will describe HCT and the patient’s and
caregiver’s experience. The role of the pre-HCT psychosocial assessment will be
presented along with a discussion of ethical considerations. The chapter will conclude
with a discussion of the significance of the problem and opportunities that may arise
when the problem is addressed.

Hematopoietic Cell Transplantation
HCT is a highly specialized field that started in the late 1960s. It is relatively
young, having transitioned only about 15 years ago from an experimental and final
treatment for advanced leukemia to a standard and even initial therapy for some diseases
(LeMaistre & Loberiza, 2005). HCT is now used to treat numerous types of blood
cancers that are broadly characterized as leukemia, lymphoma, and multiple myeloma
(National Marrow Donor Program, 2021). It is also used to treat other blood disorders,
immune system disorders, and solid tumors such as severe aplastic anemia, sickle cell
disease, testicular cancer, Fanconi anemia, myelofibrosis, thalassemia, and polycythemia
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vera (National Marrow Donor Program, 2021). Patients who undergo HCT are among the
most acutely ill and medically vulnerable oncology populations (Bevans et al., 2008). In
the United States, approximately 23,000 transplants are performed annually (D'Souza et
al., 2020). Approximately 14,000 of these are autologous transplants and 9,000 are
allogeneic transplants (D'Souza et al., 2020). By 2030, it is projected that there will be
more than 500,000 HCT survivors in the United States (Majhail, 2017).
Hematopoietic stem cells reside in the bone marrow and produce the red blood
cells, white blood cells, and platelets that circulate in the peripheral blood. Each of these
blood cells perform a specific function. Red blood cells carry oxygen to organs and
tissues; white blood cells constitute the immune system; and platelets control bleeding by
clotting the blood. HCT, also known as a bone marrow transplant, works by replacing
cancerous (or diseased) hematopoietic stem cells with healthy ones (National Marrow
Donor Program, 2019).
There are two types of HCTs: autologous and allogeneic. Some diseases are only
treated with allogeneic transplant, while others may be treated with autologous and/or
allogeneic transplant. Autologous transplants use the patient’s own hematopoietic cells.
Allogeneic transplants use hematopoietic cells donated by someone else such as a family
member, an unrelated donor, or stored umbilical cord blood (National Marrow Donor
Program, 2019).
Transplant activity has changed significantly over the past 20 years with new
technology making transplant less toxic for older adults (Artz, 2017). Twenty years ago,
allogeneic transplant was rarely performed on patients over 50. Now patients 60 and over
account for over one-third of allogeneic transplants. The number of both allogeneic and
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autologous transplants among older adults with cancer continues to increase. In 2018,
39% of allogeneic transplant recipients were 60 and older. Patients who were 70 years
and older represented 9% of transplants for cancer. Also in 2018, the majority of
autologous transplant recipients (55%) were 60 years and over and diagnosed with
multiple myeloma or lymphoma. Those 70 years and older represented 15% of
autologous transplant activity for those diseases (D'Souza et al., 2020).
Multiple myeloma and lymphoma (Hodgkin and non-Hodgkin) account for 60%
of all HCTs, the vast majority of which are autologous transplants. Acute leukemias and
myelodysplastic syndromes/myeloproliferative neoplasms (MDS/MPN) account for the
majority of allogeneic transplants (75%). Transplant activity for MDS/MPN has been
increasing since Medicare approved coverage for evidence development studies (D'Souza
et al., 2020).
In 2017, 67% of all transplant recipients were White. Patients identified as
African American or Black accounted for 12% of recipients followed by Hispanic at 11%
and Asian at 4%. Patients identified as Multiple Race accounted for 1% of all transplant
recipients (Center for International Blood and Marrow Transplant - a contractor for the C.
W. Bill Young Cell Transplantation Program operated through the U.S. Department of
Health and Human Services, 2018a). Both American Indian/Alaska Native and Native
Hawaiian/Other Pacific Islander accounted for 1%. Males account for 58% of transplant
recipients, and females account for 40% (Center for International Blood and Marrow
Transplant - a contractor for the C. W. Bill Young Cell Transplantation Program operated
through the U.S. Department of Health and Human Services, 2018b).
HCT Process
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The process of HCT starts with a preparatory regimen that uses high-dose
chemotherapy to destroy the patient’s hematopoietic cells and bone marrow. Some
patients also undergo high doses of total body radiation. The purpose of the preparatory
regimen is to kill any diseased cells and weaken the immune system so that it will not
reject the transplanted cells. Chemotherapy and radiation may last from a few days up to
a week and often result in side effects such as vomiting, diarrhea, mouth sores, hair loss,
skin rash, nausea, and fatigue (National Marrow Donor Program, 2021). To extend the
use of HCT to older adults and those with comorbidities, a less toxic regimen may be
used.
After the preparatory regimen, healthy hematopoietic stem cells are administered
through an intravenous line (no surgery is required). These cells find their way to the
bone marrow where, if the transplant works, they grow and start to produce healthy blood
cells. While the transplant itself only takes a couple hours, the treatment process takes
several weeks to many months, depending on the type of transplant. After transplant, the
patient is monitored carefully for engraftment: the growth and production of new blood
cells. Engraftment can take 30 days or longer. During this time, the patient is at the
highest risk of developing an infection that their new immune system is not yet strong
enough to handle (National Marrow Donor Program, 2021).
Some transplants occur inpatient, and others are performed on an outpatient basis.
When inpatient, patients are isolated in their rooms to avoid infection. For allogeneic
transplants, inpatient admissions last an average of 36 days for patients who undergo high
intensity preparatory regimens versus 27 days for patients who undergo lower intensity
preparatory regimens (Broder et al., 2017). For autologous transplants, the average length
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of the hospital stay is 22 days (Broder et al., 2017). After hospital discharge, patients
have clinic appointments multiple times per week (Applebaum et al., 2016). When
performed on an outpatient basis, the patient typically needs to visit the clinic daily for
labs and monitoring (Applebaum et al., 2016). HCT clinics typically operate 7 days per
week, so patients are able to have labs drawn, see a provider, and receive intravenous
antibiotics and blood transfusions any day they need. Given the frequency of clinic
appointments and need to get to the clinic quickly when signs of infection arise,
transplant centers require patients to reside nearby the transplant center, which means
some have to relocate for weeks to months.
Caregiver Role
HCT is not to be undergone alone. Patients are required to have a 24/7 caregiver
from their own support system after their hospital discharge. Allogeneic recipients are
typically required to have a 24/7 caregiver for a minimum of 100 days post-transplant,
and autologous recipients are typically required to have one for a minimum of 30 days.
The role of the caregiver is vital to the transplant process. Some centers will not perform
a transplant without one, and some formalize the importance of the role by asking
caregivers to sign non-legally binding contracts to affirm their availability, understanding
of, and commitment to the role.
Caregivers are responsible for providing post-transplant care at home. Because
waiting to address symptoms can result in serious complications, one of the most
important caregiver roles is to monitor the patient for new problems, especially signs of
infection, and report them to the HCT team immediately (National Marrow Donor
Program, 2021). Caregivers also help with medication management, changing the
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dressing on the central intravenous line, transportation to the clinic, communicating with
the medical team, cleaning surfaces and doing laundry to minimize bacteria and viruses,
taking care of children and pets, running errands, and safe food preparation (Langer et al.,
2020; National Marrow Donor Program, 2021). Caregivers often take care of finances
and also provide emotional support to the patient (National Marrow Donor Program,
2021).
Post-Transplant
It takes 6-12 months for the immune system to “adequately” reconstitute after
autologous HCT. After allogeneic HCT, it can take 2 years or more (Majhail, 2017). Until
then, patients need to avoid people, places, and things that contain bacteria, viruses,
fungi, and molds that could cause a life-threatening infection. Some of these precautions
include staying away from large gatherings and crowded places i.e. malls. Food safety for
transplant patients includes avoiding foods that are more likely to contain bacteria: soft
cheeses, bulk foods/items from self-service bins, deli and lunch meats, raw fish,
refrigerated smoked fish, and unwashed fruits and vegetables. Safe food preparation
guidelines include washing all fruits and vegetables, not touching raw meat and fish,
using separate cutting boards for raw and cooked foods, cleaning can tops with soap and
water before opening them, and heating lunch meat until it steams. Patients are
encouraged to not eat away from home until the HCT physician deems it is safe. Even
then, patients are advised to avoid delis, potlucks, buffets, street vendors, and crowded
restaurants (National Marrow Donor Program, 2021).
Late complications. Late complications are medical issues that occur months to
years after HCT. Since late complications can result in “significant long-term morbidity
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and mortality,” transplant survivors’ relative mortality rates remain higher than their peers
in the general population (Majhail, 2017, p. 220). The preparatory regimen, with its high
dose chemotherapy and radiation exposures, contributes to the development of many late
complications. Chemotherapy and radiation prior to the transplant process also
contribute. Some late complications include cataracts, severely dry eyes, eye irritation,
mouth pain and dryness, skin rashes, sun sensitivity, scleroderma (hard, tight skin),
avascular necrosis (bone breaks down in the joint), and osteopenia (weak bones)
(National Marrow Donor Program, 2021).
Secondary cancers are the cause of 5-10% of deaths among transplant patients
who survive 2 years or longer (Majhail, 2017). Therefore lifelong cancer screening posttransplant is recommended. Transplant-related exposures may impact any organ, and “the
risk for most organ specific late complications continues to increase with time” (Majhail,
2017, p. 221). Ongoing surveillance for these problems is recommended for all HCT
recipients. Given the time it takes for the immune system to adequately reconstitute,
infections are a common cause of late morbidity and mortality. Also, pre-transplant
immunity is lost, so HCT patients need to start getting vaccinations anywhere from 6-12
months post-transplant (Majhail, 2017).
Since allogeneic transplant uses donated cells, the patient becomes a chimera:
their blood contains the donor’s genetics, while the genetics in the rest of their body
remain their own. The transplanted white blood cells (graft), which constitute the immune
system, may recognize any part of the body (host) as foreign and attack it. This common
complication is called graft-versus-host disease (GVHD). GVHD is characterized as
acute and chronic. Acute GVHD develops within weeks to months after transplant, and

8

chronic GVHD typically develops within one year (National Marrow Donor Program,
2021).
Patients with chronic GVHD typically have at least 3 involved areas. The most
commonly involved areas include the skin, mouth, liver, and eyes. The gastrointestinal
tract, lungs, joints, and genital tract also tend to be involved. Examples of GVHD
symptoms include severe eye itching, dryness, and irritation that does not subside; trouble
opening the mouth, mouth sores, and mouth irritation that does not subside; itchy skin
and rashes, nail changes, and thickening of the skin; trouble breathing and persistent
cough; muscle pain and cramps; pain and stiffness in joints; nausea, vomiting, diarrhea,
and stomach pain (National Marrow Donor Program, 2021).
For cancer patients, mild GVHD is desirable. It signals a “graft vs. malignancy”
effect in which the new immune cells are detecting and eliminating any remaining cancer
cells (Costanzo et al., 2013). Severe graft vs. host disease can be fatal. GVHD and its
treatment (immunosuppressive agents) are associated with worse quality of life and
impaired physical functioning (Khera, Storer, et al., 2012). Chronic GVHD that requires
years of immunosuppression is a major cause of long-term morbidity and late mortality
(Majhail, 2017; Wingard et al., 2011).
Medical Outcomes Statistics
According to Majhail (2017), “Disease relapse is the main cause of treatment
failure in the first 2-4 years after transplantation.” (p. 220). An estimated 80 – 90% of
patients whose disease remains in remission for 2-5 years after transplant will live
another 10 years (Majhail, 2017). For adult patients, three-year probabilities of survival
post-HCT range from 27% - 87% depending on many factors including transplant type,
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disease type, disease status, and donor type (D'Souza et al., 2020). For example, among
patients who received an autologous transplant for diffuse large B-cell lymphoma, the 3year probabilities of survival were 67% and 47%, for patients with chemosensitive and
chemoresistant disease, respectively (D'Souza et al., 2020).
Allogeneic transplant entails a higher risk of morbidity and mortality than
autologous transplant (D'Souza et al., 2020). The 3-year probabilities of survival among a
cohort of patients with acute myelogenous leukemia (AML) who received an allogeneic
transplant with an unrelated donor were 53%, 50%, and 27% for patients with early,
intermediate, and advanced disease, respectively. Survival for chronic lymphocytic
leukemia is slightly better than AML with the 3-year probabilities of survival being 60%
and 54% for patients who received a transplant from a fully-matched sibling and
unrelated donor, respectively (D'Souza et al., 2020).
Cost
Given the increasing emphasis placed on cost-effectiveness and cost containment
in health care, it is important to consider the economic burden of HCT. The Agency for
Healthcare Research and Quality has noted that among all procedures, HCT has had one
of the most rapid increases in hospital costs (Stranges et al., 2007). Due to its complexity,
allogeneic transplant is more expensive than autologous transplant (Broder et al., 2017).
A study that used an administrative claims database found that the average cost of health
care resource utilization in the 2-year period after allogeneic transplant was $600,000,
with 59% of this occurring in the first 90 days and 88% occurring in the first year. For
autologous transplant, the total cost was $344,000, with 45% of the cost occurring in the
first 90 days and 72% occurring in the first year (Bonafede et al., 2017). While the exact
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figures vary among studies (Khera, Zeliadt, et al., 2012; Majhail et al., 2009; Majhail et
al., 2013; Saito et al., 2008; Saito et al., 2007), it remains clear that HCT is a costly
procedure.
The Patient Experience
Emotions
Protective isolation is inherent to the HCT process. Isolation “aims to prevent
infection by diminishing the likelihood of contact between the patient and the external
world, through the use of structural equipment and strict behavioural rules for healthcare
providers, patients, and visitors” (Biagioli, 2017, p. 2). Substantial variability in isolation
guidelines exists among transplant centers, and in recent years, guidelines have relaxed
some in light of evidence that most infections arise from normal bacteria that live and
grow on the patient’s skin, nose, and mouth (Biagioli et al., 2017). Qualitative studies
have explored patients’ experiences with protective isolation. Patients have reported
feeling abandoned, lonely, bored, and confined (Cohen et al., 2001). They have also
voiced wanting to protect their family members from seeing them in a debilitated state
(Cohen et al., 2001). Feeling lonely and isolated is not only related to the absence of
others but to the unique experience that is understood by so few people in their support
system (Stephens, 2005).
It is well documented that patients experience heightened anxiety and distress in
the days leading up to transplant (Hermioni L. Amonoo et al., 2019; Bevans et al., 2008;
Corman et al., 2021; Syrjala et al., 2004). Insomnia is also heightened during this time,
with one study finding that 50% of patients reported pre-transplant insomnia compared to
27% of matched, non-cancer controls (Lee et al., 2017). Approximately 15% of patients
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endorse depressive symptoms pre-transplant, and 37% endorse them in the week after
transplant (El-Jawahri et al., 2015). One study of recipients of autologous (n = 30) and
allogeneic transplant (n = 60) found that 43% had “clinically significant depression” at 6
months post-HCT (El-Jawahri et al., 2016).
A scoping review of studies that included autologous and/or allogeneic recipients
who are at least one-year post-transplant found a prevalence of depression ranging from
12-30% (Bevans et al., 2017). Risk factors were younger age, female gender, poor social
support, disease relapse, chronic pain, chronic GVHD (Bevans et al., 2017), and lower
self-reported physical functioning (Barata et al., 2020). Autologous and allogeneic
recipients with documented depression who take antidepressant medications have
reported better physical functioning than patients with undertreated and untreated
depression (Barata et al., 2020). Those with treated depression still reported worse
physical functioning than controls (Barata et al., 2020).
A seminal study by Syrjala et al. (2004) prospectively examined recovery over 5
years in recipients of autologous and allogeneic transplant. A total of 317 patients with
leukemia or lymphoma enrolled; 120 were still alive at the 5-year follow-up, of which 21
had recurrent malignancy. Outcomes including physical limitations, return to work,
depression, and distress related to treatment/disease were measured prior to HCT, at 90
days, and at 1, 3, and 5 years. At 1 year, only 19% had recovered on all outcomes, and by
5 years, 63% reported no major limitations. Among patients without recurrent
malignancy, 84% returned to full-time work by 5 years. Women, patients with physical
complications post-HCT, and those with lower social support pre-HCT were more
depressed post-HCT. Those with lower social support pre-HCT were slower to recover in
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terms of distress. Physical recovery occurred earlier than psychological or work recovery.
The authors concluded that “full recovery” occurs gradually over 3-5 years (Syrjala et al.,
2004).
Studies have reported the prevalence of “emotional distress” as ranging from
22%-43% in recipients who were at least one-year post-transplant (Bevans et al., 2017).
Risk factors for heightened distress have included lower income, higher education, lower
social support, physical limitations, chronic GVHD, more aggressive disease or
treatment, neurocognitive problems, and greater perceived impact of treatment (Bevans et
al., 2017).
Study findings on the prevalence of post-traumatic stress disorder (PTSD)
symptoms after transplant have been mixed. In their study of 691 transplant recipients,
Liang et al. (2019) found that rates of PTSD symptomology were relatively low (3.3%) in
HCT recipients at least 6 months post-transplant. Shorter time since transplant, but no
other demographic or transplant-related variables, were associated with a greater
likelihood of reporting PTSD symptoms in this sample. El-Jawahri et al. (2016) found
that among 67 patients, 28% met criteria for PTSD at 6 months post-transplant. In this
study, a decline in quality of life and increase in depressive symptoms during HCT
hospitalization were significant predictors of PTSD. Time since transplant may help
explain the difference in reported rates. The median time since transplant was 10.1 years
in Liang et al.’s (2019) sample. In El-Jawahri et al.’s (2016) sample, PTSD was measured
at 6 months.
Cognition
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Studies on cognitive outcomes have had small sample sizes (Burns et al., 2018)
and results have been inconsistent secondary to differences in methods and definitions of
constructs (Scherwath et al., 2013). When measured with neuropsychological testing,
anywhere from 10%-40% of patients experience cognitive dysfunction a year or more
after transplant (Bevans et al., 2017). When measured by patient self-report, the rate is
higher: 40% - 60% (Bevans et al., 2017). Recipients of allogeneic transplant with a highintensity preparatory regimen have been found to exhibit significant cognitive decline
compared to healthy controls, while those with a lower intensity preparatory regimens
have been found to have cognitive decline later but not immediately post-transplant
(Sharafeldin et al., 2018). Cognitive function does not seem to be impacted in recipients
of autologous transplant (Sharafeldin et al., 2018).
Sexual Health and Fertility
Sexual dysfunction may be one of the most prevalent and persistent late effects
after HCT (Tierney, 2004). Both women and men report a decline in sexual function after
transplant, with women reporting worse decline than men (Noerskov et al., 2016). Rates
of sexual dysfunction in survivors more than one-year post-HCT vary across studies with
anywhere from 6%-46% of men and 33%-80% of women reporting problems (Bevans et
al., 2017). Examples of sexual concerns include decreased libido, erectile and ejaculatory
dysfunction, ovarian failure leading to premature menopause, vaginal dryness, and
painful intercourse (Humphreys et al., 2007; Tierney, 2004). For men, sexual function
declines after total body radiation (Wong et al., 2013). Chronic GVHD in both men and
women contribute to sexual dysfunction and dissatisfaction (Wong et al., 2013).
Infertility is common among HCT survivors due to the toxicity of the preparatory
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regimen (Joshi et al., 2014). A study comparing 10-year survivors with case-matched
controls found that the prevalence of infertility and the reporting of fertility-related
concerns was higher among the recipients than the controls (Hammond et al., 2007).
Finances and Work
Relative to other outcomes, the financial consequences of HCT is a newer area of
inquiry. One of the first studies was a survey that had 268 respondents from a single
institution (16% were < 1 year post-transplant, 53% were 1-3 years post-transplant, and
31% were > 3 years post-HCT) (Khera et al., 2014). All patients were insured. Even so,
patients reported cutting back on or not getting prescription medication (19%), not having
a medical test or not seeing a provider (21%), and deferring a medical service i.e.
physical therapy (28%) related to cost burden. For 38% of patients, out-of-pocket costs
for 3 months were greater than $2000.00, and for 12%, costs were above $5000.00. A
total of 73% reported that undergoing HCT had hurt them financially, and 3% had
declared bankruptcy (Khera et al., 2014).
In their study of 190 recipients with chronic GVHD from 10 different transplant
centers, Khera et al. (2019) found that 24% reported difficulty paying medical bills, 28%
reported running out of money at the end of the month, 49% reduced spending on utilities
and in other areas, 31% used retirement savings, and 16% borrowed money or sold
assets. Patients who reported financial burden were more likely to report feelings of
anxiety and depression and have trouble sleeping. A total of 34% of the sample had
experienced delayed/denied insurance coverage for GVHD treatment. Notably, 73% of
respondents had a graduate degree, and nonrespondents had lower pre-HCT income and
lower education (Khera et al., 2019). Thus, financial consequences may be more severe
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than captured by the study. Regarding return to work, studies have found that anywhere
from 15%-40% of patients do not return to their previous employment (Bevans et al.,
2017). Risk factors for not returning to work include lower income, female gender,
chronic GVHD, physical impairment, and more hospitalizations (Bevans et al., 2017).
Regret
Cusatis et al. (2020) examined decisional regret among patients who underwent
allogeneic transplant. Regret was measured at 100 days, 6 months, and 1 year posttransplant. Of 184 patients, 28 unique patients (15%) reported feeling some amount of
regret at any time point. At each time point, 6-8% expressed regret. Patients who
expressed regret also reported having worsening quality of life at each time point. Lastly,
the risk of decisional regret was 18% higher for those with disease recurrence (Cusatis et
al., 2020). These results are congruent with findings from a qualitative study where some
patients expressed that if they had known what their quality of life would be posttransplant, they would not have had one (Jim, Quinn, Gwede, et al., 2014).
Adjustment and Coping
Many patients find adaptive ways to cope with the process of HCT. A qualitative
study of survivors found that optimism, or having the “right” frame of mind, about
survival was important (Beeken et al., 2011). Some balanced this emphasis on optimism
by highlighting the importance of acceptance and not being unrealistic. Patients also
expressed that they thought they had little control over their outcome and engaged in
activities to distract them from thinking about disease recurrence (Beeken et al., 2011).
Recipients also identified that changing their expectations about their physical
functioning helped them cope (Beeken et al., 2011).
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The Caregiver Experience
The HCT process takes a toll on caregivers’ well-being. They have “extensive
responsibility for the recipient’s well-being and safety” (Cooke et al., 2011, p. 502) and
have to juggle other responsibilities including parenting, work, and sometimes caregiving
for parents/in-laws (Langer et al., 2020). This toll, before, during, and after transplant, is
well-documented.
Similar to patients, caregivers report high levels of anxiety and distress pre-HCT
(Simoneau et al., 2013). They also report intrusive thoughts, avoidant behavior, and sleep
problems that exceed population norms (Simoneau et al., 2013). In the first 100 days
post- transplant, the patient’s symptom management needs are a particular source of
distress for caregivers (Applebaum et al., 2016). Some caregivers have reported being
well-informed about how to care for the patient and what symptoms to anticipate (Jim,
Quinn, Barata, et al., 2014), but others feel unprepared (Gemmill et al., 2011). Caregivers
have reported feeling less prepared for helping the patient with emotional and cognitive
changes (Jim, Quinn, Barata, et al., 2014) and that supporting the patient emotionally was
the hardest caregiving activity (Cooke et al., 2011). Not surprisingly, when patients have
greater needs, caregivers report more distress and less ability to maintain paid
employment and relationships (Akgul & Ozdemir, 2014).
Qualitative studies have found that caregivers talk much more frequently about
the negative psychological impacts than positive ones (Langer et al., 2020) and that
caregivers voice more negative life changes related to transplant than patients do (Jim,
Quinn, Barata, et al., 2014). Caregivers have voiced anxiety, fear, worry, being
overwhelmed/overloaded, frustration, anger, irritation, devastation, loneliness, guilt,
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resentment, unhappiness, helplessness, fear about cancer recurrence, and high anxiety
before follow-up appointments (Jim, Quinn, Barata, et al., 2014; Langer et al., 2020).
One caregiver described the transplant process as “horrific” (Langer et al., 2020).
Another spoke about the experience of fear, “You hear one story after another of who
doesn’t get to go home when they are supposed to. And one story after another of whose
cancer has returned. And whose graft fails…And it really gets to you. So you just live in
fear.” (Langer et al., 2020).
Many caregivers have “described constant vigilance about disinfecting their
surroundings to prevent infection, sometimes far longer than required by the transplant
team” (Jim et al., 2014, p. 1234). Caregivers have also reported feeling overlooked, since
family members’ and friends’ concerns centered exclusively on the patient (Jim, Quinn,
Barata, et al., 2014). Caregivers have reported that their relationship with the recipient
was significantly changed due to the HCT process. For some, transplant brought them
closer, while for others, it brought significant strain to the relationship (Jim, Quinn,
Barata, et al., 2014). Some have also described losing their identity (Jim, Quinn, Barata,
et al., 2014).
Recent survey research from a single institution assessed caregivers’ quality of
life (Jamani et al., 2018). The 849 respondents were a median of 6 years post-HCT (IQR
2-15 years); 67% were female, and 68% reported they were still providing care to the
recipient. While mean and median quality of life measures were at or above general
population norms, 20% still reported poor quality of life compared to general population
norms. Also, the prevalence of depression and sleep disorders were higher than in the
general population. Lower caregiver quality of life was associated with female gender,
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younger age, lower educational attainment, and lower recipient quality of life (Jamani et
al., 2018). In the HCT caregiver literature in general, most caregiver participants are
female, White, partnered, and employed full time, which limits the generalizability of
conclusions and implications (Applebaum et al., 2016).
Spousal Caregivers
The impact of HCT specifically on spousal caregivers has been studied. Years
after transplant, the risk of depression among spousal caregivers has been found to be 3.5
times greater than their matched peers (Bishop et al., 2007). One study of patients (n =
691) and caregivers (n = 333) who were a median 10 years post-HCT found that
significantly more caregivers than patients reported PTSD symptoms (6.6% vs. 3.3%; p =
0.02) post-transplant (Liang et al., 2019). Patients’ report of PTSD symptoms was
associated with shorter time since transplant, but caregivers’ was not. Those who
endorsed PTSD reported significantly higher levels of distress related to uncertainty,
family strain, medical demands, finances, identity, and health burden (Liang et al., 2019).
Langer et al. (2010) studied marital adjustment and satisfaction in patients and
their spouses in a 5-year longitudinal study. They found that female spouses of male
patients had higher rates of relationship maladjustment. Pre-HCT, 9% of female spouses
scored in the relationship-maladjusted range; this rose to 24% at 6 months and remained
elevated during the study timeframe. While couples were mostly satisfied and divorce
was uncommon, female spouses of male patients again were more likely to not be
satisfied. They reported decrements in satisfaction at each time point relative to their
baseline. For the first 2 years, their male spouses (patients) did not report dissatisfaction,
but from 3-5 years, they did report reduced satisfaction (Langer et al., 2010).
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Taken together, evidence on the caregiver’s experience suggests significant,
negative short-term impacts. Many recover over a period of months to years but some do
not. Accordingly, it seems that HCT takes as much of a toll, if not more, on the caregiver.

Psychosocial Assessment of HCT Candidates
Given the arduous nature of HCT, patients undergo an extensive pre-transplant
evaluation to ensure they are medically eligible and adequately informed. The evaluation
includes medical tests and educational sessions. At most centers, it also includes an indepth psychosocial assessment, typically conducted by a clinical social worker. The
psychosocial assessment serves many purposes. It identifies psychosocial factors that
require intervention before or close monitoring throughout the transplant process to
ensure the best possible outcomes (Austin & Rini, 2013). It also captures baseline
functioning to which post-transplant outcomes may be compared. The assessment also
provides an opportunity for the social worker to establish rapport with the patient and
family and begin addressing their psychosocial needs. Finally, the assessment informs
clinical decisions such as referrals to allied health professionals. (Austin & Rini, 2013).
One clinical decision the assessment may inform is whether or not to proceed
with transplant. Some psychosocial factors are thought to contribute to risk and poor
outcomes. The presence of these is considered in the overall risk assessment and
evaluation. In rare cases, patients who would otherwise be medically eligible for HCT are
excluded based on psychosocial factors (Foster, McLellan, Rybicki, Tyler, et al., 2009;
Richardson, Devine, et al., 2018). Patients facing transplant often have few alternative
treatment options. Their diseases are life-limiting and/or life-threatening; non-HCT
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options may provide them some time but not a potential cure. Therefore, when a patient is
otherwise medically eligible, not offering transplant due to psychosocial factors, is a
difficult judgment call and an ethical dilemma.
There is a paucity of literature about this ethical issue. A survey of HCT social
workers, nurses, physicians, and hospital ethics committee chairpersons examined which
psychosocial factors they thought posed the most risk. Participants were asked to respond
to 16 case vignettes, each presenting a challenging psychosocial situation, with whether
they would recommend proceeding with HCT or not. The situation most frequently
identified by respondents as “do not proceed” was “suicidal ideation” (87%), followed by
“uses addictive illicit drugs” (82%), “history of non-compliance” (81%), “lives far away
and has no caregiver” (69%), “alcoholic” (65%), “mild dementia/Alzheimer’s disease”
(64%), “significant financial problems” (48%), “morbidly obese” (27%), “caregiver has
mental problems” (24%), “daily use of marijuana” (18%), “cognitively impaired” (18%),
“borderline personality disorder” (17%), “controlled schizophrenia” (16%), “two suicide
attempts” (16%), “treated for major depression” (16%), “current tobacco smoker” (16%),
and convicted of a felony (12%). (Foster, McLellan, Rybicki, Tyler, et al., 2009).
Some centers have policies around psychosocial eligibility, but others do not
(Randall et al., 2021). Clinical practice guidelines for psychosocial eligibility have not
yet been published. Therefore, the extent to which psychosocial factors impact eligibility
varies from center to center, and even from physician to physician within the same center
(Richardson, Devine, et al., 2018). Tay et al. (2018) assert that the decision whether to
proceed should be interdisciplinary and that psychosocial factors should be considered as
“tie-breakers” when the potential benefit of HCT is unclear.
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The potential for psychosocial assessment results to be used to exclude patients
from HCT is a weighty matter. The psychosocial factors identified as “high risk” are
those that also tend to be stigmatized by society and used to label patients as “difficult.”
These patients are already marginalized and at risk of not accessing the health care they
need. They are also the people that the social work profession has a particular call to
serve and advocate for (National Association of Social Workers, 2021).
Conceptualizing Psychosocial Elements
Despite the various roles of the pre-HCT psychosocial assessment, the
psychosocial elements that should be assessed in HCT candidates have not been
rigorously conceptualized. Furthermore, there are no formal consensus guidelines on
what should be assessed or on how to adequately measure psychosocial factors. This has
led to practice variation (Hong et al., 2016; Trask et al., 2002). Some centers use an
interview only and others use one of several standardized tools to summarize
psychosocial risk based on the interview (Richardson, Devine, & Nash, 2018). Some
centers also incorporate psychometric measures into their assessment protocol (Randall et
al., 2021)
Practice variation has inhibited high quality psychosocial research (Muffly &
Artz, 2018). Centers produce different quality psychosocial data, which may or may not
be useful for research. They also produce different types of data, which limit studies to
single center designs with small sample sizes and limited power to detect differences.
Single center designs are a particular limitation for research with more psychosocially
vulnerable patients, since they constitute a minority of the patients who undergo HCT at
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any given center (Foster et al., 2009; Sanghee Hong et al., 2019; Richardson, Huang, et
al., 2018).
There is a need to conceptualize the psychosocial elements that should be
assessed in HCT candidates. A rigorous conceptualization would fill a gap in the
literature and produce an underlying framework. The framework could inform the
creation of an assessment protocol. If implemented broadly, the protocol would constitute
a high and consistent standard for evaluating patients. It would also help ensure that
uniform psychosocial data were consistently gathered, thus promoting psychosocial
research.
Concept mapping is a mixed-methods, participatory methodology that produces a
conceptual framework (Kane & Rosas, 2018) that may be used to develop tools for
evaluation (Rosas & Camphausen, 2007). This research uses concept mapping
methodology to conceptualize the psychosocial elements that should be assessed in HCT
candidates.
Research questions include:
1. How do psychosocial professionals conceptualize the elements they assess in
candidates for hematopoietic cell transplantation?
2. Is there a difference in the conceptualization based on the use of standardized
risk rating scales in clinical practice?
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CHAPTER II: LITERATURE REVIEW

This chapter will review the literature that conceptualizes psychosocial elements
that are assessed in different medical specialty areas. The empirical literature
investigating the relationship between pre-HCT psychosocial factors and post-transplant
outcomes will then be summarized and critiqued. Key theoretical models that underpin
this literature will be presented. Lastly, the philosophical underpinnings of this study’s
methodology will be presented.

Conceptualization of Psychosocial Elements in Specialty Care Contexts
Psychosocial factors have been conceptualized in literature on experimental spinal
cord injury treatment (Fronek, 2004), living organ donation (Ismail et al., 2015), solid
organ transplantation (Dew et al., 2000; Maldonado et al., 2012; Olbrisch et al., 1989;
Twillman et al., 1993), oncology (Schnipper & Varner, 2015a) and HCT (Futterman et al.,
1991; Garcia Jr et al., 2005; Kennedy, 1993). These conceptualizations vary based on the
primary purpose of the assessment and unique characteristics of the patient population
and treatment. Some conceptualizations have been used to develop assessment tools.
Experimental Treatment for Spinal Cord Injury
Based on a literature review and clinical experience, Fronek (2004)
conceptualized psychosocial elements in the context of assessing candidates for
experimental spinal cord injury treatment. The purpose of assessing candidates is “to
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ensure emotional, social, and psychological stability of the participant; identify the
individual’s capacity to deal with negative or positive consequences of participation in
the project; assess informed consent and to ensure the principles of nonmaleficence and
beneficence are upheld” (p. 6). The conceptualization is organized into 4 equallyweighted domains: person, current environment, disability, and informed consent. The
domains are not independent but represent “a complex and dynamic interrelation of
influences, which together create a picture of that individual’s current functioning.”
(Fronek, 2004, p. 10).
Unlike HCT patients, individuals with spinal cord injury are not sick. They do not
have a life-threatening illness; they experienced a trauma that caused a permanent
disability. Assessing aspects of the disability is pertinent for this patient population and
comprises one-quarter of the conceptual model. Similarly, the domain of informed
consent for the treatment is deemed so important that it comprises one-quarter of the
conceptual model. The treatment is experimental, so one of the primary purposes of the
assessment is to evaluate factors (i.e. understanding of the treatment and its risks,
coercion, and motivation) that bear on informed consent. (Fronek, 2004).
Living Organ Donation
Ismail et al. (2015) conceptualized psychosocial elements in the context of
evaluating potential living kidney and liver donors. They conducted a systematic review
of published guidelines and used group concept mapping methods to create a visual
representation of the psychosocial elements and their interrelationships. They also
analyzed the elements’ relative importance and how commonly each was assessed in
practice. This resulted in 6 domains listed in order of importance: 1) motivation and
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decision making, 2) personal resources, 3) psychopathology, 4) social resources, 5)
ethical and legal factors, and 6) information and risk processing.
That “motivation and decision making” was found to be the most important
domain reflects the unique context of living organ donation. Living donors are healthy
individuals who elect to undergo a medical procedure that entails some risks and that
provides them no direct medical benefit. Ensuring appropriate motivation and sound
decision-making is therefore paramount (Massey et al., 2018). Elements in other domains
are also unique to the donor population: financial benefit for undergoing the procedure,
expectations of the effect on the relationship with the recipient, and health outcome
expectations for the recipient.
Solid Organ Transplantation
Dew et al. (2000) specified “the elements that are encompassed by the term
psychosocial” as it applies to solid organ transplantation (SOT) candidates (p. 240). In
this context, the purpose of psychosocial assessment is to inform clinical decisions such
as whether the patient is eligible to be put on the waiting list and what supports they may
need throughout the transplant process. Also, improved psychosocial status from pre- to
post-transplant signals the relative success of the transplant.
Their conceptualization contains 7 core domains: 1) psychiatric history and
current status, 2) compliance history and current status, 3) substance use history and
current status, 4) mental status, 5) social history and availability of support, 6) family
social and mental health history, 7) perceived health, coping style, and quality of life.
Within each domain, additional details are provided. For example, social history and
availability of support includes the following areas: “employment status, marital status
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and relationship stability, living arrangements, financial status; contact, availability, and
emotional supportiveness of family, friends, and community or religious organizations;
religious beliefs and orientation; concurrent stressors (work related, home related, other)”
(Dew et al., 2000, p. 240).
In addition to Dew et al.’s (2000) conceptualization, Olbrisch et al. (1989),
Twillman et al. (1993), and Maldonado et al. (2012) conceptualized “psychosocial risk
factors” in the context of SOT and created scales for psychosocial professionals to rate
candidates’ risk: Psychosocial Assessment of Candidates for Transplantation (PACT),
Transplant Evaluation Rating Scale (TERS), and Stanford Integrated Psychosocial
Assessment for Transplantation (SIPAT), respectively. The elements rated in each scale
are presented in Table 1. All of the scales have been applied to HCT patients and will be
discussed in turn.
Table 1. Psychosocial risk factors identified by the PACT, TERS, and SIPAT
Psychosocial Element

PACT TERS SIPAT

Quality of affect

X

Compliance with treatment

X

X

Coping with disease and treatment

X

Prior history of coping

X

Drug and alcohol use

X

X

X

Alcohol use/abuse/dependence

X

Alcohol use/abuse/dependence – Risk for recidivism

X

Substance use/abuse/dependence (including prescribed and
illicit substances)

X

Substance use/abuse/dependence (including prescribed and
illicit substances) – Risk for recidivism

X
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Nicotine use/abuse/dependence

X

Effect of truthfulness vs. deceptive behavior in presentation

X

Family or support system availability

X

X

Family or support system stability/functionality

X

X

Quality of family/social support

X

Healthy lifestyle, ability to sustain change in lifestyle

X

Health behaviors

X
X

Appropriateness of living space and environment

X

Prior psychiatric history (DSM-III-R Axis I)

X

Prior psychiatric history (DSM-III-R Axis II)

X

Psychopathology, stable personality factors

X

Risk for psychopathology

X

X

Presence of psychopathology (other than personality
disorders and organic psychopathology)

X

History of organic psychopathology or neurocognitive
impairment

X

Influence of personality traits vs. disorder

X

Mental status (past and present)

X

Relevant knowledge and receptiveness to education

X

Knowledge and understanding of the transplant process

X

Knowledge and understanding of medical illness process

X

Willingness/desire for transplant

X

*Shading is used to demarcate groups of similar elements.
Psychosocial Assessment of Candidates for Transplantation (PACT). The
PACT was developed in the late 1980s based on a literature review and the clinical
experience of researchers at one transplant center. It was created to address ethical
concerns about unjust exclusion from SOT based on inconsistently applied psychosocial
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criteria (Olbrisch et al., 1989). Accordingly, the purpose of the scale was to study the
clinical judgment of raters. The psychosocial professional completes the PACT after their
clinical interview to rate a patient’s psychosocial risk in 8 domains as well as provide
initial and final overall risk ratings (Olbrisch et al., 1989).
Transplant Evaluation Rating Scale (TERS). The TERS is a 10-item rating
scale that is completed post-interview to classify a patient’s psychosocial risk in 10
domains. The TERS was designed to “foster further research into the relative impact of
psychosocial factors on organ transplant outcome and posttransplant quality of life”
(Twillman et al., 1993, p. 145). It was revised from the Psychosocial Levels System
(PLS), a tool for assessing HCT candidates, to increase specificity and relevance to the
SOT setting (Twillman et al., 1993). Weighted scores for each variable were developed
by the authors, but subsequent research found that the weighting system provides no
more predictive utility of outcomes than simply summing unweighted item scores
(Hoodin & Kalbfleisch, 2001).
Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT).
The SIPAT was created to address the problem of unclear psychosocial listing criteria and
unclear methods for assessing psychosocial risk (Maldonado et al., 2012). It was
developed based on a literature review of psychosocial variables that may influence
adherence, quality of life, and organ rejection. It “intends to assess the psychosocial
factors that appear to better predict patients’ adherence and graft survival.” (Maldonado et
al., 2012, p. 126). The SIPAT includes 18 factors that are organized into 4 domains:
patient’s readiness level, social support system, psychological stability and
psychopathology, and lifestyle and effect of substance use. The evaluator rates the factors
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based on their interview with the patient and collateral information (Maldonado et al.,
2012).
The authors applied weights to each item because the evidence suggested to them
that some psychosocial factors are more predictive of outcomes than others. They tested
the scale retrospectively on a sample of 102 liver, heart, and lung transplant patients and
found high inter-rater reliability among the 5 raters (Pearson’s correlation coefficient =
0.853) as well as predictive utility for dichotomous psychosocial outcomes of “positive”
and “negative” (Maldonado et al., 2012). The SIPAT is more detailed than the PACT and
TERS. Also, unlike the PACT and TERS, the SIPAT provides direction on how
depression, anxiety, and cognitive functioning should be measured. It suggests using the
Patient Health Questionnaire-9 or Beck Depression Inventory, the Generalized Anxiety
Disorder-7 questionnaire or Beck Anxiety Inventory, and the Mini Mental Status Exam if
available. If the instruments are not available, the evaluator is directed to use their clinical
judgment.
Oncology
Practice standards for psychosocial assessment published by the Association of
Oncology Social Work include 9 areas: 1) age and stage of human development; 2)
knowledge about cancer and its treatment, including level of understanding, expectations,
and goals for treatment, 3) characteristics of the support system; 4) patient and family
psychosocial functioning including strengths, limitations, and coping skills; 5) race,
ethnicity, religion, culture, language, physical or mental disability, socioeconomic status,
sexual orientation, and gender identity; 6) barriers to care; 7) availability and adequacy of
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community resources; 8) patient and family’s interest in participating in care and medical
decision-making; 9) development of a case plan (Schnipper & Varner, 2015b).
Hematopoietic Cell Transplantation
An early article on the role of the social worker in HCT recommended that four
broad areas should be assessed pre-transplant: 1) the patient’s and family’s psychosocial
history, 2) family structure and family roles, 3) family’s communication and decisionmaking patterns, preexisting psychological and social problems, and coping skills, and 4)
the patient’s, family’s, and donor’s expectations and perceptions of the illness and HCT
(Kennedy, 1993).
Psychosocial Levels System (PLS). Two years prior to Kennedy’s (1993) article,
Futterman et al. (1991) proposed a psychosocial rating scale based on a review of the
literature. The PLS contains 7 items that the psychosocial professional rates postinterview to classify a patient’s risk: prior psychiatric history, quality of family/social
support, prior history of coping, coping with disease and treatment, quality of affect,
mental status (past and present), and proneness to anticipatory anxiety (Futterman et al.,
1991). The purpose of the PLS is to identify patients at risk for developing emotional
challenges during HCT as well as provide a common language of psychosocial variables
for the interdisciplinary transplant team (Futterman et al., 1991, p. 177). In contrast to
other psychosocial rating scales, compliance and substance use are not listed.
The researchers agreed, based on their clinical experience, that the psychosocial
domains varied in importance and amount of contribution to the overall level of risk.
Thus, through multiple discussions, three raters (2 licensed clinical psychologists and 1
doctoral-level clinical psychology graduate student) ordered the items according to their
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theoretical beliefs about the relative contribution of each to overall risk and then assigned
a priori weights (Futterman et al., 1991). The domain “prior psychiatric history” carries
double the weight of the second heaviest domains, “quality of family/social support’ and
“prior history of coping.” The researchers tested the tool in a retrospective chart review of
42 HCT patients at one center. Testing showed strong concordance between raters
(Futterman et al., 1991). It is unclear if the tool underwent further testing, as it does not
appear in the literature again.
Psychosocial Assessment Interview of Candidates for Hematopoietic Stem
Cell Transplantation (PAIC-HSCT). The PAIC-HSCT (147 items) is a structured
interview with open-ended and multiple choice questions and also includes the Brief
Psychiatric Rating Scale (Garcia Jr et al., 2005). It was developed based on the PACT,
TERS, and questions from a structured interview for kidney transplant candidates. It
contains 11 domains: social and demographic data, comprehension of the illness,
comprehension of the transplantation, medical compliance, lifestyle, coping strategies,
mental status exam, psychiatric history, family history, social and family support, and
expectations of the transplant. The researchers submitted their initial tool to 13 HCT
professionals for review and made changes based on their feedback. Then one researcher
pilot-tested the tool on 30 HCT candidates, concluding, based on patients’ feedback, that
it was feasible (Garcia Jr et al., 2005).
The PAIC-HSCT is unique from the PLS, TERS, PACT, and SIPAT in that it
structures the clinical interview via open-ended and multiple choice questions and does
not include a risk rating scale. Like the PLS, after its initial publication, it does not appear
in the literature again. Based on a national survey of HCT centers, it seems likely that
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neither the PLS nor the PAIC-HSCT are currently used in clinical practice (Randall et al.,
2021).

Summary of the Conceptual Literature
In summary, the conceptual literature shows that broad psychosocial domains are
relatively similar across the medical settings. Even so, there are some subtler differences
in the conceptualizations related to the patient population and nature of the medical
intervention (i.e. the importance of informed consent for experimental surgery and for
organ donors). SOT has produced the most literature. This literature focuses specifically
on psychosocial risk factors, which may be a subset of all the elements that should be
assessed. This focus is likely due to the responsibility to fairly allocate scare organ
resources among many patients in need. Thus, they are seeking to maximize the outcomes
from each organ. Accordingly, much of that work has focused on psychosocial elements
that are thought to bear on medical and quality of life outcomes, which in turn affect
eligibility to be placed on the organ waiting list. In contrast, one patient receiving donated
hematopoietic stem cells does not mean that another patient in need will not receive
them. Psychosocial factors in HCT then, are considered relative to the risk for each
patient, irrespective of other patients.
The item weightings of the PLS, TERS, and SIPAT conceptualize the relative
priority of the scale items. In the PLS, prior psychiatric history was given the heaviest
weighting (4.0), followed by quality of family/social support (2.0), prior history of coping
(2.0), coping with disease and treatment (1.5), quality of affect (1.5), mental status (1.0),
and proneness to anticipatory anxiety (0.5) (Futterman et al., 1991). The weightings of
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the TERS are similar: prior psychiatric history Axis I (4.0), prior psychiatric history Axis
II (4.0), substance use/abuse (3.0), compliance (3.0), health behaviors (2.5), quality of
family/social support (2.5), prior history of coping (2.5), coping with disease and
treatment (2.5), quality of affect (1.5), and mental status (1.0) (Twillman et al., 1993).
Subsequent testing of the TERS found that the weighting system provided no additional
predictive utility (Hoodin & Kalbfleisch, 2001). The PLS and TERS weightings
demonstrate that psychiatric history was conceptualized as the most important contributor
to risk for emotional difficulties and worse transplant outcomes. Weightings for the
SIPAT could not be found.
Within the limited body of literature, the methods used to conceptualize
psychosocial elements vary in their level of rigor from clinical experience and
unsystematic literature review to concept mapping. They also vary in their level of
participation from the psychosocial professionals who actually conduct assessments, with
most being developed with minimal participation. For example, only 1 of 7 authors of the
SIPAT was a social worker; the majority were physicians. The concept mapping study
with professionals in living organ donation (Ismail et al., 2015) generated the most
participation. Of 26 participants, 9 were psychologists. Other disciplines represented
included physician, lawyer, philosopher, sociologist, transplant nurse/coordinator,
transplant surgeon, and ethicist. At most HCT centers, social workers are responsible for
performing the pre-HCT psychosocial assessment, yet their firsthand knowledge and their
voices are absent from this literature.
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Relationships Between Pre-HCT Psychosocial Factors and Outcomes
The relationship between psychosocial factors and HCT outcomes is an active
area of inquiry. If adverse psychosocial factors can be proactively identified, then
interventions may be employed to improve clinical outcomes. Evidence of this
relationship pertaining to survival and other outcomes will be reviewed.
Survival
An early systematic review evaluated 12 studies that investigated the effect of
psychosocial factors on post-transplant mortality in adult patients (Hoodin & Weber,
2003). Categories of variables included social support, depressed mood,
psychopathology, coping style, quality of life, and “other” (compliance, family support,
individual maturity, marital adjustment, smoking history, and substance use). The authors
concluded that the literature was insufficiently developed to determine a relationship
between pre-HCT psychosocial factors and survival (Hoodin & Weber, 2003). This
conclusion stemmed from methodological shortcomings such as small sample sizes,
retrospective designs, and psychosocial measures lacking sensitivity to adequately
measure constructs (Hoodin & Weber, 2003).
Three years later, Hoodin et al. (2006) conducted a “mini review” that integrated
new data with the data previously reviewed by Hoodin and Weber (2003). The mini
review sought to answer the question of whether negative or positive emotions
differentially impact post-HCT mortality. The authors noted improvement in
methodological quality owing to multivariate analysis to control for confounding factors
and longer follow-up periods to handle high attrition related to morbidity and mortality.
The “negative emotions” investigated included major and minor depression as assessed
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by the DSM-IV criteria and other depressive symptomatology measured by scales. The
15 studies varied according to the measures used, which included 7 standardized scales
that had psychometric data and brief, researcher-developed self-report questionnaires. In
light of the new evidence, the authors concluded that negative emotion pre-HCT was an
independent risk factor for worse long-term survival (Hoodin et al., 2006). The effect of
positive emotions, such as optimism and hopefulness, improved survival in the short-term
(Hoodin et al., 2006).
Since Hoodin et al.’s (2006) review, many studies have examined the relationship
between psychosocial variables and post-HCT survival. Variables that have been
investigated include overall psychosocial risk, health-related quality of life, depression,
anxiety, psychopathology, distress, coping style, social support, substance use, knowledge
of treatment, lifestyle factors, compliance, marital status, race/ethnicity, and
socioeconomic status (SES).
Psychosocial risk. Four studies that tested the relationship between overall
psychosocial risk as measured by the TERS (Richardson, Huang, et al., 2018) and the
PACT (Foster, McLellan, Rybicki, Dabney, et al., 2009; Harashima et al., 2019; Hong et
al., 2019) found that scores did not predict survival. Solh et al. (2020) found that
intermediate-to-high psychosocial risk as measured by the TERS was associated with
lower overall survival and higher non-relapse mortality among patients (n=457) with
low-to-intermediate disease risk. Among patients (n=90) with high risk disease, though,
the TERS score was not associated with outcomes. This finding suggests that
psychosocial factors may not significantly impact mortality in patients who are already at
high risk of it due to their disease (Solh et al., 2020).
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Health-related quality of life. One study assessed the effect of pre-HCT healthrelated quality of life (HRQoL) on survival. HRQoL was not defined, but the literature
generally considers it a subjective, multidimensional concept that includes a person’s
functioning and ability to experience a fulfilling life in psychological, social, and physical
domains (Bevans et al., 2017; International Society of Quality of Life, 2021). HRQoL
was measured with the Short Form-36, and findings showed that it was not predictive of
survival in recipients of autologous transplant (Wood et al., 2015). In recipients of
allogeneic transplant, however, the physical health component of quality of life, but not
the mental health component, was strongly predictive of survival (Wood et al., 2015).
Emotional factors. Many studies have examined the effect of pre-HCT
depression on survival. El-Jawahri et al. (2017) found that depression was not associated
with survival among autologous patients (n = 3786) but did predict worse survival for
allogeneic patients (n = 7433). Sample size was a strength of this study, but measurement
was a limitation. Depression was measured via a single-item reported by transplant center
staff to a registry database. The item asks, “Is there clinically significant depression
requiring treatment?” This wording may be interpreted differently by different staff,
which poses a problem for the reliability and validity of this data. Barata et al. (2020)
found that depression, as measured by a score of 10 or greater on the PHQ-8, did not
have an effect on overall survival in a sample of recipients who had received allogeneic
HCT and a sample who had received autologous HCT. As measured by two subscales on
the BSI-18, neither depressive nor anxiety symptoms predicted survival. (Pillay, Lee,
Katona, Burney, & Avery, 2014). When measured by the Million Behavioral Medicine
Diagnostic, depression did not affect 1 year-mortality in allogeneic transplant recipients
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(Pereira et al., 2010). The PACT items, “psychopathology/stable personality factors” and
“risk for psychopathology” have been found to have no effect on mortality (Foster,
McLellan, Rybicki, Dabney, et al., 2009; Harashima et al., 2019; Hong et al., 2019). The
mainly null findings of these studies conflict with Hoodin et al.’s (2006) review that
found an association between “negative emotions” and survival.
Studies have examined the relationship between pre-HCT distress and survival.
Among 4 studies, distress was measured in 5 different ways. Of the two studies that used
investigator-constructed ratings, one found that distress was unrelated to survival (Ehrlich
et al., 2016), while the other found that patients with distress had a higher 1-year
mortality rate compared to those who did not (Park et al., 2010). The latter study
categorized patients as having “distress” if a diagnosis of adjustment disorder, anxiety
disorder, delirium, dementia, mood disorder, personality disorder, or substance abuse was
documented in their medical record. The study that measured distress specifically related
to cancer and its treatment using the Cancer and Treatment Distress Scale (CTXD) found
no association between distress and survival in autologous or allogeneic patients (Knight
et al., 2016). When measured with the Brief Symptom Inventory (BSI-18), patients with
higher scores on the somatic symptoms subscale, called “somatic distress” by the authors,
had poorer survival (Pillay et al., 2014). Scores on the subscale measuring “global
distress” were not associated with mortality (Pillay et al., 2014).
This literature has strengths and limitations. The studies have large enough
sample sizes to use multivariate statistics. Statistical analyses are consistent, though there
is some variation in the number of demographic and medical covariates analyzed.
Measurement is a limitation. Studies varied greatly in their measurement of psychosocial
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constructs. The retrospective nature of the studies likely contributed to this. Also, samples
are not geographically diverse enough to represent the general HCT population. With the
exception of a few national samples, the published literature represents specific
geographic locales: Illinois, Ohio, Florida, Seoul (South Korea), Melbourne (Australia),
and Tokyo (Japan). Therefore, caution should be used in generalizing the results. The age
of the data is another limitation. Among the eight studies that reported time periods, the
range for data collection was 2000-2017, with only two studies including data collected
no earlier than 2010. Changes in HCT practice over time limit the comparability of data
collected earlier vs. later.
Coping style and spirituality. Research on coping style and spirituality is
limited. In their investigation of a relationship between coping style and survival, Pillay
et al. (2014) used the Mental Adjustment to Cancer (MAC) subscales to examine coping
styles include fighting spirit, anxiety/preoccupation, helpless/hopeless, fatalism, and
avoidance. They found no relationships with survival. A study that investigated the
relationship between “spiritual absence” and survival after allogeneic HCT found that
individuals with the highest spiritual absence scores were more likely to die within 1 year
of transplant (Pereira et al., 2010). The measure in this study assessed “the degree to
which patients lack religious or spiritual personal resource to cope with medical
stressors.” (Pereira et al., 2010, p. 1172).
Social support. Findings on the relationship between social support and postHCT survival have been mixed. A 2013 systematic review identified 6 studies that
investigated this relationship (4 published articles, 1 dissertation, and 1 abstract) (Beattie
et al., 2013). Of the articles, the most recently published was in 2005. The dissertation
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was completed in 2007, and the abstract was published in 2011. Three of the published
studies and the abstract found an association between better support and survival (Colón
et al., 1991; Foster et al., 2005; McLellan et al., 2011; Rodrigue et al., 1999), but the
dissertation, which was the largest study (n = 272) found no association (Artherholt,
2007). In this literature, social support was measured inconsistently with both validated
scales (Artherholt, 2007; Frick et al., 2005) and investigator-constructure measures
(Colón et al., 1991; Foster et al., 2005; McLellan et al., 2011; Rodrigue et al., 1999).
Most of the research examined the presence of social support. Frick et al. (2005) was the
only study to examine the quality of support. They found that “positive” social support
did not influence survival but that “problematic” social support, as measured by the
Illness Specific Scales of Social Support, was associated with poorer survival (Frick et
al., 2005).
Literature published since (or not included) in Beattie et al.’s (2013) review has
also contained mixed findings. Ehrlich et al. (2016) retrospectively reviewed
psychosocial assessment reports that were documented in the medical record of 400
recipients of allogeneic transplant and coded each patient as having “poor support” or
“good support.” Good emotional support predicted longer survival (Ehrlich et al., 2016).
Other studies that have examined social support have used the PACT items of “family or
support system stability” and “family or support system availability.” Foster, McLellan,
Rybicki, Dabney, et al. (2009) found that better scores for family or support system
availability predicted decreased risk of mortality, but Harashima et al. (2019) and Hong et
al. (2019) found no association.
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There is much opportunity for increased rigor in this area of research. Social
support is a complex construct, and it has been conceptualized and measured in different
ways in this literature. Future research should be guided by theory of how social support
influences health (main effect or buffer) and should include conceptual definitions of
social support. It should also apply more sophisticated measurement instruments for both
perceived and received support.
Substance use. An early, retrospective, single center study identified 17 patients
with “lifetime substance abuse” and compared their survival with 17 patients matched on
clinical variables (Chang et al., 1997). The patients with “lifetime substance abuse” were
found to have worse survival, a difference that persisted after stratifying for transplant
type and cigarette smoking (Chang et al., 1997). Another retrospective, single center
study reviewed medical records from 2000-2010 to identify “alcohol use disorder”
(AUD) among patients who underwent autologous transplant for lymphoma (Graf et al.,
2016). Within the sample of 754 patients, 86% were white, median age at transplant was
53 (range 18-78), and 11% (n=81) were identified as having AUD. Findings showed
AUD was associated with worse survival. Analysis of AUD, comorbidity index score,
and age as 3 risk factors found that non-relapse mortality by day 100 post-transplant
(surrogate for treatment-related mortality) increased from 1% in patients with no risk
factors, to 3% in patients with 1 risk factor, 6% in patients with 2 risk factors, and then to
27% in patients with all 3 risk factors (Graf et al., 2016). The PACT item, “drug and
alcohol use" has been found to not be associated with survival (Foster, McLellan,
Rybicki, Dabney, et al., 2009; Harashima et al., 2019; Hong et al., 2019).
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The body of literature that examines the relationship between substance use and
survival is extremely limited. The age of the data and retrospective nature of the studies is
a limitation. Reliability and validity in the measurement of substance use is another
limitation. The studies that used older data classified patients as having substance use
based on chart review. Given the stigma around substance use, patients may not share this
information, or if they do, they may not share it accurately. Also, providers may
inconsistently document it in the medical record. Studies using the PACT rely on a single
item rated by the psychosocial professional. The item does not distinguish between drug
and alcohol use. Patients, knowing they are being evaluated for HCT eligibility, may not
fully disclose their substance use. Overall, the amount and rigor of the empirical evidence
does not substantiate the conclusion that patients with substance use fare worse with
transplant.
Other PACT items. Foster, McLellan, Rybicki, Dabney, et al. (2009) found that
better scores on “relevant knowledge and receptiveness to education” as measured by the
PACT item predicted decreased risk of mortality, but Harashima et al. (2019) and Hong et
al. (2019) found that it did not. The item, “healthy lifestyle, ability to sustain change in
lifestyle” has been found to have no relationship with survival (Foster, McLellan,
Rybicki, Dabney, et al., 2009; Harashima et al., 2019; Hong et al., 2019). Two of three
studies found that “compliance with medications and medical advice” was not associated
with survival (Foster, McLellan, Rybicki, Dabney, et al., 2009; Hong et al., 2019), while
one found that poorer compliance was associated with worse survival (Harashima et al.,
2019).
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Marital status. Evidence on relationship between marital status and posttransplant survival conflicts. Some studies have found no relationship (Colón et al., 1991;
Frick et al., 2005; Molassiotis et al., 1997; Tschuschke et al., 2001) but some have found
that being married is an advantageous prognostic factor (Hoodin et al., 2004; Pillay et al.,
2014). A recent, large study used data reported to an observational database to examine
the relationship between marital status and survival post-HCT among patients 40 and
older who had undergone autologous (n = 5714) or allogeneic (n = 10,226) transplant
(Tay et al., 2020). Marital status was defined as being married or living with a partner.
Median follow-up was 40 months (range: 1-106 months) in the autologous cohort and 37
months (range: 1-102 months) in the allogeneic cohort. Results showed that marital status
was not associated with survival in either of the cohorts (Tay et al., 2020). The age of
much of the literature is a limitation. The relationship between marital status and survival
may be moderated by gender and dimensions of social support i.e. type and quality (Aizer
et al., 2013). Measuring dimensions of social support and conducting analyses that
account for potential differences in effect based on gender could help clarify this
literature.
Race and ethnicity. A review by Majhail, Nayyar, Burton Santibañez, et al.
(2012) included 9 studies that examined differences in outcomes among people of color.
Four included only patients undergoing autologous HCT for multiple myeloma (Hari et
al., 2010; Khaled et al., 2009; Saraf et al., 2006; Verma, Howard, & Weiss, 2008); four
included patients undergoing allogeneic HCT for acute and chronic leukemias (Baker et
al., 2009; K. S. Baker et al., 2005; Ballen et al., 2010; Serna et al., 2003); and one
included patients undergoing autologous and allogeneic transplants for multiple

43

diagnoses (Mielcarek et al., 2005). For autologous transplant, one study found that black
patients had worse survival than white patients (Khaled et al., 2009), and 4 studies (Hari
et al., 2010; Mielcarek et al., 2005; Saraf et al., 2006; Verma et al., 2008) found no
association between race and survival. For allogeneic transplant, analyses of data from
1985-1999 and 1990-2000 found that patients identified as Hispanic had worse survival
than non-Hispanic whites but that blacks and Asians had comparable survival to nonHispanic whites (Baker et al., 2005; Serna et al., 2003). Analysis of data from a single
institution from 1992-2000 and analysis of data reported to a national registry between
1995-2004 found that recipients of allogeneic transplant who were black had worse
survival compared to whites, controlling for socioeconomic status (Mielcarek et al.,
2005). Taken together, the evidence suggests that patients of color are at risk for worse
survival after allogeneic HCT; the evidence is mixed for post-autologous survival
(Majhail et al., 2012).
Since Majhail et al.’s (2012) review, two studies (Ailawadhi et al., 2017;
Bhatnagar et al., 2015) have found no differences in survival according to race after
autologous transplant. A single center, retrospective study conducted with 296 patients
(73% NHW and 27% people of color) who underwent allogeneic transplant for leukemia
and lymphoma found that survival was comparable between the two groups (Khera et al.,
2015). This study also measured medical resource utilization post-transplant (inpatient
admissions, length of stay, emergency room visits, and outpatient visits) and found that it
was comparable between NHWs and people of color. The researchers posited that the
comparable survival in their sample was explained by the uniform post-transplant
treatment approach at their center (Khera et al., 2015).
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The small body of literature that examines the relationship between race and
ethnicity and HCT outcomes is retrospective and uses data from a national registry or
from a single center. National registry data tends to lack details about psychosocial
variables, and even the single center designs, because they are retrospective, are
inherently limited in the types of data they can use. The current literature does not
explicitly state the theoretical framework(s) that guides the inquiry. Future research
should use prospective designs and incorporate social science theory. This would take
inquiries beyond the characteristic of socially-assigned race and inform the selection of
instruments to measure structural and other important factors such as perceived everyday
racism and neighborhood segregation.
Socioeconomic status. A large, heterogenous sample found no effect of SES on
overall survival (Knight, Syrjala, et al., 2016). Other research in HCT that has found low
SES, independent of race, has been associated with worse survival (Baker et al., 2009;
Silla et al., 2009).
Summary Critique
Overall, the literature that examines the relationship between psychosocial
variables and survival lacks specified theoretical frameworks. It also contains varied
methodological quality and scattered use of measures. Given this, it is difficult to make
conclusions about what psychosocial variables may influence survival after HCT.
Moreover, the answer to this question is likely a moving target based on continuing
advancements in transplant medicine. For example, the availability of lower intensity
preparatory regimens meant HCT could be offered to older adults and individuals with
comorbidities. Therefore, in the last 10 years, the transplant population has become an
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increasingly older population (Burns, March 23, 2021). Also, two drugs recently
approved by the U.S. Food and Drug Administration (ruxolitinib and ibrutinib) have the
potential to improve outcomes for patients experiencing steroid-refractory acute and
chronic GVHD (Burns, March 23, 2021).
Future research could be enhanced with reporting of theoretical frameworks that
guide the research, clearly conceptualized psychosocial variables, prospective designs,
consistent use of instruments that have good reliability and accumulated evidence of
validity in oncology/medical populations, and a standard set of medical and demographic
covariates. Finally, it is critical that researchers delineate the variables that are most likely
to influence survival and focus rigorous research efforts on them.
Other Outcomes
Medical outcomes other than survival that have been studied include healthrelated quality of life, readmission, nonadherence, and immune reconstitution.
Health-related quality of life. H. L. Amonoo et al. (2019) conducted a
systematic review of literature examining the association between positive psychological
constructs and health outcomes in HCT. Positive psychological constructs were defined
as constructs that characterize individuals who feel positive about life and function well
psychologically. Examples of these include optimism, hope, gratitude, perseverance,
vitality, meaning, purpose in life, personal growth, and contentment. The authors found
18 eligible studies with a total N = 4201 and mean age = 47. Optimism was the most
frequently studied construct (12 studies) and health-related qualify of life was the most
frequently studied outcome (11 studies). The 17 studies with quantitative analyses all
found an association between a positive psychological construct and better health
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outcomes. Of the studies that reported race/ethnicity, 79% of study participants were nonHispanic white.
Hospital readmissions. Hospital readmissions are an outcome of interest, since
studies have found a positive association between readmissions and mortality in HCT
patients (Richardson, Huang, et al., 2018). TERS overall psychosocial risk rating was
found to be associated with risk of hospital readmission within 90 days but not length of
inpatient transplant stay (Richardson, Huang, et al., 2018). In the same study, TERS items
for prior psychiatric history and poor coping skills that were scored as at-risk also
predicted readmission (Richardson, Huang, et al., 2018). Among patients considered
psychosocially high-risk, readmission for infection was more common; readmissions for
other causes did not differ significantly between the high-risk and low-risk groups. Only
2% of patients were identified as noncompliant, and these were more likely to be
readmitted (Richardson, Huang, et al., 2018).
Nonadherence. Nonadherence to the post-transplant regimen can lead to lifethreatening complications. Overall, patients at greater risk for nonadherence are those
who are younger, male, and express concerns about medical costs (Bevans et al., 2017).
Mumby et al. (2011) studied a cohort of patients undergoing autologous transplant on an
outpatient basis. They defined nonadherence as “refusal of oral hygiene, prescribed
exercise programs, oral nutrition, and/or prescribed medications” (p. 556). This definition
resulted in 80% of patients (n = 121) being labeled as nonadherent. Men and patients with
elevated depression scores were more likely to be nonadherent. Stepwise regression
models found that gender, depression, global distress, and nausea and vomiting severity
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predicted noncompliance with the interaction of gender and psychological variables
explaining most of the variance (Mumby et al., 2011).
Mishkin et al. (2019) examined whether overall psychosocial risk, as measured by
the SIPAT, predicted nonadherence. They defined nonadherence as “at least one lifethreatening nonadherence event in the first 6 months post-transplant,” which resulted in
18 (21%) of patients being labelled nonadherent (Mishkin et al. 2019, p. 2223). Results
showed an independent association between the SIPAT score and nonadherence after
controlling for type of transplant, age, sex, and disease.
Immune reconstitution. Immune reconstitution has been an outcome of interest
for biobehavioral research. Faster return of immune system function has been associated
with fewer side effects and better survival (Auletta & Lazarus, 2005; Porrata et al., 2008).
Psychosocial variables that have been studied as predictor variables include anxiety,
depression, distress, socioeconomic status, optimism, compliance, and substance use.
McGregor et al. (2013) studied a cohort of 70 autologous transplant recipients
who were 93% non-Hispanic White, 55% male, and an average of 38 years old. They
measured cancer and treatment-related distress, anxiety, and depression pre-transplant,
and they measured white blood cell count recovery on days 5-22 post-HCT. Using linear
mixed model regression analyses that controlled for gender and treatment-related
variables, they found that higher anxiety and depression subscale scores as measured by
the Symptom Checklist-90-R were associated with slower white blood cell recovery.
Scores on the Cancer and Treatment Distress scale were not associated with white blood
cell recovery (McGregor et al., 2013).
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Knight, Rizzo, et al. (2016) examined the relationship between low
socioeconomic status and expression of a gene profile that has been associated with
worse survival. SES was measured as patient income estimated by mean household
income tied to their residential zip code. While planning to analyze racial and ethnic
groups separately, the samples were insufficient, so their analysis is limited to nonHispanic whites only. Patients of lower SES were found to be more likely to express the
adverse gene profile. Even so, the largest and most heterogenous samples (n = 646
autologous and allogeneic recipients) found no effect of SES on neutrophil (type of white
blood cell) and platelet engraftment (Knight, Syrjala, et al., 2016). Variables associated
with low SES prior to transplant in this study were worse physical functioning, distress,
and poor sleep quality.
Knight et al. (2014) examined the effect on pre-transplant optimism and anxiety
on the number of days to engraftment. They found that higher optimism and lower
anxiety were associated with fewer days to engraftment in recipients of autologous but
not allogeneic transplant. This association, however, did not hold when they reduced the
sample to only those patients who completed their surveys before engraftment (Knight et
al., 2014). Engraftment is a significant and celebrated milestone, so patients’ self-reports
of optimism and anxiety after this event may be altered and not accurately reflect their
pre-engraftment emotional state.
Finally, Foster, McLellan, Rybicki, Dabney, et al. (2009) found that better scores
on the PACT item for compliance were associated with faster neutrophil and platelet
engraftment and that better scores on the drug/alcohol use item were associated with
faster platelet engraftment.
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Summary Critique
This literature examines the relationship between psychosocial factors and
outcomes that are hypothesized to influence survival. The independent and outcome
variables that have been studied are scattered, which has resulted in a lack of
accumulated evidence between any one psychosocial factor and non-survival medical
outcome. Researchers should delineate the most salient factors and non-survival
outcomes and focus their research efforts on those.

Theoretical Models
There is an abundance of theoretical literature elucidating the complex
relationships between psychosocial factors and biomedical factors/outcomes. While not
explicitly stated, the literature reviewed in the previous section is generally underpinned
by these models. This section will review some key theoretical models.
Biopsychosocial Model
In 1977, George L. Engel critiqued the reigning biomedical model, which
conceptualized disease in terms of molecular biology. He argued that biological factors
alone were insufficient for conceptualizing health and illness. Instead, he proposed that
health and illness should be conceptualized in terms of biologic, psychologic, and social
factors. Drawing from a general systems theory perspective, the biopsychosocial model
proposes that all of these factors interact and influence one another to shape health and
illness. Thus this model advances a holistic understanding of the person (Engel, 1977).
McEwen’s Stress Process Model
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McEwen’s stress process model offers a framework to understand the widely
accepted relationship between stress and the development and progression of disease
(McEwen, 1998). The model suggests that people who endure more stress are more likely
to have poor health over time. Stress is defined as “a threat, real or implied, to the
psychological or physiological integrity of an individual” and may be acute (i.e. a major
event or an event that produces a flight or fight response) or chronic (i.e. minor daily
stresses) (McEwen, 2000, p. 108). Sources of stress may be physical, social, emotional,
and/or environmental (McEwen, 1998).
The model depicts the brain’s perception of stress directly influencing the body’s
physiological response to stress (i.e. activating stress hormones and the immune system).
The brain’s perception of stress also indirectly influences the physiological response
through an individual’s behavioral response (McEwen, 1998). While the physiological
response to stress protects the body in the short-term, over time it causes damage,
adversely affecting organ systems and accelerating disease processes. This wear and tear
over time is referred to as allostatic load. The heavier the load a person carries over their
lifetime, the more risk they have for morbidity and mortality (McEwen, 1998).
Andersen’s Biobehavioral Model of Cancer Stress
Andersen et al. (1994) propose a model in response to literature showing that
psychological distress and acute and chronic negative life events are linked with impaired
immune system functioning. Their model suggests mechanisms by which psychological
and behavioral responses influence biomedical processes and outcomes specific to
cancer. Specifically, their model depicts the cancer diagnosis and treatment producing
stress, which then leads to reduced quality of life. This affects the central nervous system
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and neuroendocrine system and results in in lower immunity. Lower immunity has direct
and reciprocal impacts on both localized cancer and metastatic disease, ultimately
affecting the course of the disease. In addition to impacting immunity, stress also directly
influences compliance and health behaviors. Compliance and health behaviors have a
reciprocal relationship with one another.
Health behaviors impact immunity. For example, distressed individuals may be
more likely to engage in unhealthy eating, cigarette smoking, and substance use. They
also may have difficulty sleeping and be less likely to exercise. These behaviors
negatively impact immune system functioning. Compliance impacts both local and
metastatic disease. For example, noncompliance in attending radiation therapy
appointments or stopping the prescribed course of radiation early may lead to treatment
failure at the local site. Similarly, not taking oral chemotherapy as prescribed and not
returning for follow-up monitoring could lead to failure to control metastases.
Compared to McEwen’s (1998) model, Andersen et al.’s (2004) model focuses
more on proximal contributors and pathways for disease progression and outcomes.
Accordingly, it does not include environmental-level factors associated and accumulated
stress load over a lifetime. The role of immunity as the link between psychological and
behavioral factors and disease course seems particularly salient in the setting of HCT,
where treatment involves destroying, in whole or in part, the patient’s immune system.
Biobehavioral Model of Recovery Post-HCT
Costanzo et al. (2013) proposes a model by which psychosocial factors influence
post-HCT outcomes. Their model highlights “psychosocial/behavioral factors” including
mood/affect, psychological stress, protective cognitive and behavioral processes, and
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social support. Stress from these factors is proposed to activate the neuroendocrine and
sympathetic nervous systems and innervate the bone marrow. These processes modulate
immune cell recovery and inflammation post-HCT. Immune recovery and inflammation
influence engraftment, infections, and graft vs. host disease, which in turn impact clinical
outcomes including disease relapse, survival, and quality of life (Costanzo et al., 2013).
Like Andersen et al.’s (2004) model, immune system functioning is a key mechanism.
Also like Andersen et al.’s (2004) model, intrapersonal and interpersonal factors, but not
environmental-level factors, are considered.

Philosophical Underpinnings for this Study
Postmodernism and constructivism form the philosophical base for this study and
will be discussed briefly.
Postmodernism
According to Howe (1994), “The most pervasive notion [of postmodernism] is
that there are no transcendent, universal criteria of truth, judgement and taste that can be
applied to all situations at all times in all places” (p. 520). Truth is localized and
dependent on context. Truth is interpreted, and its meaning is embedded in language. As
language changes, so do meaning and truth. Truth evolves to serve different purposes and
can only be appraised within its own local context where it meets perceived needs and
serves specific purposes. (Howe, 1994).
Postmodernism champions pluralism and embraces multiple realities. (Howe,
1994). It de-centers power by having no absolute authorities or privileged perspectives.
Instead of having their realities defined by special holders of knowledge and power,
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individuals who have historically had less power are invited to participate in social
discourse, shaping it with the knowledge of their experiences (Howe, 1994).
Application. The psychosocial elements that should be assessed in HCT
candidates is specific to HCT. While it is useful to consider what factors are assessed in
other contexts, it is imperative that the community of HCT psychosocial professionals
speak to assessment in their context. This concept mapping study de-centers power by
inviting active participation among psychosocial professionals whose experience is not
currently captured in the literature. It invites them to voice their experience, and it values
this as a contribution to knowledge.
Constructivism
Constructivism asserts that reality does not exist in an empirical way but is
created by the individual as they interact with their environment (Berger & Luckmann,
1966). Thus, reality is determined by the individual’s experience. Social constructionism,
closely related to constructivism, claims that individuals’ knowledge of the world is
mediated by their socially shared understandings within a society or culture, and their
behavior is influenced by the meaning the make of events, not the events themselves.
Individuals are also constrained by the external structures of society, including relational
processes through which patterns of norms and expectations are established (Berger &
Luckmann, 1966).
Application. This study assumes that psychosocial professionals construct
knowledge based on their individual experiences. Their knowledge is influenced by the
meaning they make while working with patients and families undergoing HCT. Their
knowledge is also influenced by their social work or psychology education, professional
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socialization, transplant center processes/protocols, and relationships with their team
members and social work colleagues. Through their experiences, study participants
construct their realities. Concept mapping methods elicits this from them and represents
the composite reality of the participants in a conceptual framework.
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CHAPTER III: METHODOLOGY

The purpose of this study is to explicate a conceptual framework of psychosocial
elements assessed in candidates for hematopoietic cell transplantation (HCT) and to
explore differences in the conceptualization based on the use of risk rating scales in
clinical practice. As discussed in chapter 2, current conceptualizations do not contain the
perspective of those who actually perform this clinical work. Therefore this study uses a
participatory methodology that engages the voices of those previously unheard and seeks
to capture the diversity of their thoughts regarding a topic in which they have special
knowledge. Research questions include:
1. How do psychosocial professionals conceptualize the elements they assess in
candidates for hematopoietic cell transplantation?
2. Is there a difference in the conceptualization based on the use of standardized
risk rating scales in clinical practice?
Because the study is exploratory, there are no hypotheses.

Concept Mapping
Overview
Concept mapping is a mixed methodology that uses multivariate statistics to
analyze qualitative data (Kane & Trochim, 2007). It is a systematic process used to elicit,
compile, and organize the ideas of a group of stakeholders (Kane & Trochim, 2007). The
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process yields a composite framework, or conceptualization, that is visually represented
in a series of maps. Concept mapping has many uses: theory building, program and
intervention planning, evaluation, and developing scales and measures (Kane & Rosas,
2018).
Since it was introduced 30 years ago, concept mapping methodology has been
used in many academic areas including education (Morley et al., 2017; Winseman et al.,
2015; Ziring et al., 2018), nutrition (Keita et al., 2016; Reppond et al., 2018; Walker et
al., 2010), child welfare (Miller et al., 2017; Miller & Jones, 2015; Ridings et al., 2010),
community wellness (Burke et al., 2009; Dulin Keita et al., 2016; Kading et al., 2019),
violence prevention (Maddox et al., 2019; Snider et al., 2010; Vives-Cases et al., 2017),
and gerontology (Anderson et al., 2014; Bennett et al., 2018; Conrad et al., 2011).
Concept mapping has also been used in cancer care. Some examples of study purposes in
cancer care include identifying barriers to cancer screening (Lobb et al., 2013; Weinstein
et al., 2015), translating research into clinical practice (Graham et al., 2008; Vinson,
2014), and survivorship needs of adolescents and young adults (Hydeman et al., 2019).
In their foundational text on the methodology, Kane and Trochim (2007) describe
six steps in the concept mapping process: 1) preparing, 2) generating the ideas, 3)
structuring the statements, 4) analyzing the data, 5) interpreting the maps, and 6) using
the maps. Each step builds upon the previous and will be reviewed in turn.
Prepare
To prepare for a concept mapping study, the researcher identifies the domain of
conceptualization (Trochim, 1989b). For this research, the conceptual domain was
identified as psychosocial elements that should be assessed in HCT candidates. The
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researcher then prepares focus prompts to be used in the brainstorming phase and the
rating activity (Kane & Trochim, 2007). A brainstorming focus prompt provides direction
to the participants and helps capture their ideas about the conceptual domain. There are
two commonly used types of prompts (Kane & Trochim, 2007). One is a statement
instruction: “Generate ideas about (the topic).” Another is an incomplete sentence that
participants would finish: “A successful outcome means…” This study used a statement
instruction: “Generate short phrases that describe elements that should be assessed in an
HCT candidate.” This prompt type made sense given that participants were provided with
an initial statement set. The rating activity focus prompt provides participants instructions
on rating the ideas in the statement set. For this study, the rating prompt was, “In your
view, how important is this item for the quality assessment of a transplant candidate?”
Sampling and participants. The researcher identifies and selects participants for
the concept mapping process (Trochim, 1989b). Participants may represent a broad or
narrow range of stakeholders, depending on the purpose of the study and utilization of the
maps (Kane & Trochim, 2007). Clinical social workers and psychologists who work in
HCT were selected for this study because of their ability to contribute information needed
to answer the research questions. Both have knowledge and experience in assessing HCT
candidates that has not been represented in the literature. Furthermore, they will use the
maps to create an assessment protocol for their clinical practice.
The goal of sampling “is to achieve a broad sampling of ideas rather than a
representative sampling of persons” (Kane & Trochim, 2007, p. 36). For this study,
participants were selected for the brainstorming phase based on their availability to
participate in an in-person session at the Association of Oncology Social Work’s (AOSW)
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annual conference. A non-random, purposive sample was recruited via emails sent to
AOSW membership. While brainstorming may be done remotely and even
asynchronously, the in-person format had the following advantages: face-to-face
interaction, no technological difficulties, not having to schedule across time zones, higher
and more focused participation due to no distraction from demanding caseloads, and
team-building that could promote the study’s subsequent tasks.
It is not necessary for participants to participate in all phases of the concept
mapping process, though the resulting maps tend to be better understood by those who
have (Kane & Trochim, 2007). Participants in the brainstorming phase were offered the
opportunity to participate in the sorting and rating phases. To increase the number of
participants, additional participants were recruited via email for the sorting and rating
phases. This occurred through invitation sampling. The researcher contacted participants
who had participated in the brainstorming phase and in previous survey research and who
had expressed a desire to be involved with the project. Inclusion criteria for the study
were psychosocial professionals (social workers and psychologists) who have experience
assessing HCT candidates.
The number of participants in concept mapping may vary. According to Kane and
Trochim (2007), having 10-40 participants “seems to provide a good framework” and
ensures “a variety of opinions” (Kane and Trochim, 2007, p. 36). For the structuring
phase, Jackson and Trochim (2002) recommend a minimum of 15 participants. This study
met these standards. A total of 18 individuals, representing 16 different transplant centers,
participated in the in-person brainstorming session. Given time constraints at the AOSW
conference, the session was continued via two conference calls. A total of 12 participants
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attended the first conference call, and 8 attended the second. A total of 25 participants
participated in the sorting and rating tasks, with 18 providing usable sorting data and 24
providing usable rating data.
Preparing for the study also involved applying to the University of Louisville’s
Institutional Review Board for approval to conduct research with human subjects.
Approval was granted before any study activities with human subjects commenced. Since
the additional conference calls were a deviation in the study protocol, an amendment was
submitted and approved by the IRB before the calls were conducted. Given the low risk
of harm, informed consent was obtained via preamble before the brainstorming phase and
the structuring phase.
Generate the Ideas
In this phase, the goal is to develop an exhaustive list of items, called
“statements,” that capture the diversity of thought around the conceptual domain (Kane &
Trochim, 2007). In most concept mapping studies, group brainstorming (Diehl & Stroebe,
1991) is used to generate the exhaustive list, but Kane and Trochim (2007) mention some
alternative methods. One method is to use a predetermined statement set, e.g. based on
theoretical categories or scale items. Another method is to tap into a “naturally occurring
‘text database’” i.e. organizational reports, memos, and other documentation (Kane and
Trochim, 2007, p. 62). Groenewoud et al. (2008) used multiple sources of data to
generate a statement list: an internet search, semi-structured interviews, and associated
documents. Haque and Rosas (2010) used data from a photovoice project (photos with
captions) as their statement set. Ismail et al. (2015) developed an initial statement list
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based on a systematic literature review and then asked participants to build on this list
during the brainstorming session.
For this project, the researcher generated an initial list of items from assessment
template data that was collected in a nationwide survey of psychosocial professionals in
HCT (Randall et al., 2021). The researcher abstracted all but redundant text from the
templates until no new ideas appeared. This saturation point occurred after 20 templates.
During the in-person session facilitated by the researcher, the purpose of the research was
explained, along with the specific purpose of the brainstorming session. Participants
introduced themselves and ground rules were established. The researcher provided a
paper copy of the list to all participants in the in-person group and asked them to
contribute any other ideas based on the focus prompt. The purpose of starting with an
initial list was to maximize the limited amount of time available during the in-person
session. This method also allowed more voices to be heard. Given their anonymity, it also
allowed expression without the potential discomfort of being judged for their practice.
Thus, this method may have yielded greater breadth of thought in the statement set.
Idea synthesis. In addition to contributing new ideas to the list, participants
engaged in idea synthesis. Idea synthesis is the process used to reduce and edit the
statement set in a manner that maintains the overall integrity of the ideas. It yields a final
statement set that is considered the conceptual domain and is used in the next concept
mapping phase. (Kane & Trochim, 2007). Idea synthesis ensures that there is only one
idea per statement, that each statement is relevant to the project, and that statements are
worded clearly. Idea synthesis also ensures that the final statement set is a manageable
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size. The size of the final statement set needs to balance capturing the full breadth of the
conceptual domain with minimizing participant burden (Rosas & Kane, 2012).
It is not unusual for idea synthesis to take several hours (Kane & Rosas, 2018). It
is also not unusual to eliminate a significant number of statements during this process.
For example, Groenewoud et al. (2008) reduced a statement set (generated through
literature review) of 750 down to 178. A pooled study analysis of 69 concept mapping
studies found that there was an average of 96 statements in the final set per study (SD =
17), range 45 – 132. In this study, the initial brainstormed list contained 153 statements,
and the final statement set included 114.
Structure the Statements
The structuring phase includes two conceptual tasks: sorting and rating. The
sorting and rating activities may occur in an on-site session or electronically. Given the
geographic dispersal of participants, sorting and rating were completed electronically via
groupwisdom™, a proprietary online application (The Concept System, 2020).
Sorting refers to grouping statements into sets of like ideas according to theme or
meaning. This identifies participants’ perceptions of how the ideas relate to one another
organizes the complexity within the conceptual domain. Consistent with Kane and
Trochim’s (2007) recommendations, participants were given instructions on sorting. This
was done via a video that the researcher created to introduce the activity. The video was
embedded in the groupwisdom™ application (The Concept System, 2020) so that
participants viewed it before commencing the task. Instructions asking the participants to
1) read through all of the statements first, 2) sort each statement into a pile according to
their view of the theme or meaning, 3) group the statements for how similar they are to
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one another in theme or meaning, 4) do not create groups according to priority or value,
5) do not create categories such as ‘other’ or ‘miscellaneous’ to group dissimilar
statements, 6) if unrelated to all the other statements, put it alone in its own category, and
7) make sure every statement is sorted somewhere. These rules help ensure that
interrelationships between statements are captured in the participant’s determination of
where the statement is best located. Participants were also asked to name each pile
according to the theme or meaning. In the effort to address the potential concern
participants may have about creating the “right” number of piles, participants were
informed that people vary in how many categories they create.
After sorting, participants were asked to rate each statement’s importance. The
rating focus prompt was used: “In your view, how important is this item for the quality
assessment of a transplant candidate?” Response choices were on a 5-point Likert scale,
with higher scores reflecting more importance: Very important (5), Important (4),
Moderately important (3), Slightly important (2), Relatively unimportant (1).
The researcher included video instructions to participants as an introduction to the
rating activity. Instructions addressed the tendency to answer according to a response set
or rate the importance of all items highly (Kane & Trochim, 2006). To combat this
tendency, participants were instructed to first scan the entire list of statements to get a
sense of which ones are of relatively higher and lower importance. They were then asked
to make comparative judgments between the statements, using the full range of values,
from 1 to 5 (Kane & Trochim, 2006).
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Analysis
Concept mapping analysis uses the sorting and rating data to generate conceptual
maps and other reports. The maps and reports produced in this study’s analysis include:
point map, cluster map, point rating map, cluster rating map, pattern match, and go-zone
graphs. Each will be explained. The Concept System® groupwisdom™ application was
developed specifically for concept mapping analysis and was used in this study (The
Concept System, 2019).
Sorting analysis. Three steps, each building on the previous, form the core
analysis of the sorting data. First, individual binary similarity matrices were computed for
each participant based on how they sorted the statements. These matrices were
aggregated to produce a similarity matrix. This matrix is a square symmetric matrix
showing the number of participants who sorted each pair of statements together. Higher
values indicate greater agreement about the conceptual relationship, while lower values
indicate little (or no) conceptual relationship (Trochim, 1989b).
Multidimensional scaling. Second, multidimensional scaling (MDS) was
performed on the similarity matrix (Kane & Trochim, 2007). MDS output represents the
matrix as distances between the original statements, where each item is located as a
separate point on a two-dimensional (X, Y) plot. This plot, referred to as a point map,
consists of points representing each statement. On this map, items that are often sorted
together appear closer to one another than items not often sorted together (Kane &
Trochim, 2007).
The stress value (Kruskal & Wish, 1978) is the primary statistic of interest in
MDS. The stress value indicates the degree of discrepancy (or goodness-of-fit) between
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the MDS solution (distances on the point map) and the values in the original similarity
matrix. A lower stress value is desirable because it indicates better concordance.
According to Kane and Rosas (2018), typical concept mapping projects have stress
values ranging from 0.10 – 0.35, which signals that the map is interpretable. In their
pooled study analysis, Rosas and Kane (2012) found that the average stress value for 69
studies was 0.28 with range: 0.17 – 0.34.
Hierarchical cluster analysis. Third, hierarchical cluster analysis (HCA) is
performed on the multidimensional scaling coordinates. HCA uses resemblance
coefficients to analyze similarities in datasets (Romesburg, 2004). In concept mapping,
HCA uses Ward’s algorithm and the MDS x-y coordinate data to partition the map into
clusters (Rosas & Camphausen, 2007). Cluster parameters are defined using analysis of
variance as developed by Ward (1963). This analysis divides the coordinates, or
statements, on the point map into distinct clusters.
The bridging statistic is essential in cluster analysis. It ranges from 0 – 1 and
indicates the frequency with which a statement is sorted into a particular cluster vs. other
clusters (Kane & Trochim, 2007). Statements with lower bridging values are sorted more
frequently with statements in their immediate vicinity as opposed to statements in other
clusters. These statements are considered to reflect the meaning of that part of the map
more strongly and are referred to as “anchors.” Statements with higher bridging values
are sorted more frequently with statements in other areas of the map. These “bridges”
“suggest a broader relationship of that statement across the map, providing a ‘bridge’
from its home location to other cluster or areas” (Kane and Rosas, 2012, p. 63).
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Observing anchoring and bridging relationships is helpful to understanding the overall
meaning of the map.
Finalizing the cluster solution. There is no formula to determine the final cluster
solution, and there is no one “right” number of clusters (Kane & Trochim, 2007).
Different cluster solutions are examined and a final solution is selected based on the
aforementioned statistics and goals of the project. Some projects involve the participants
in this process, others use a small advisory group, and for some, the decision is made
solely by the researcher. For this study, the researcher worked with a member of the
dissertation committee to select a final cluster solution that fit with the goals of the study.
The researcher then labeled the clusters based on the labels that participants used when
sorting.
Rating analysis. Analysis of ratings data varies based on the needs of the
research. This study generated point rating maps, cluster rating maps, pattern matches and
go-zone graphs. Point rating maps show the average ratings of importance for each
statement. Cluster rating maps show the average importance ratings for all statements in a
cluster.
Pattern match. A pattern match compares average cluster ratings from two groups
(Kane & Trochim, 2007). The two groups in this study were participants who use
standardized psychosocial risk rating scales in their practice and those who do not.
Therefore, the pattern match examined differences in the importance ratings of each
cluster for these groups.
Go-zone graphs. Go-zone graphs are bivariate graphs that are produced for each
cluster. They are divided into quadrants based on the mean importance rating by

66

participants who do not rate risk (x-axis) and the mean importance rating by participant
who do rate risk (y-axis). The upper right quadrant (called the Go-Zone) shows
statements in the cluster that are above average in importance for both groups. The lower
left quadrant contains statements that were rated below average importance by both
groups. The upper left and lower right quadrants, then, show statements that were rated
higher than average by one group but not the other. Go-zone displays are particularly
helpful for detailing subsequent planning efforts (Kane & Trochim, 2006).
Interpretation
Concept mapping provides many different visual outputs that represent aspects of
the group’s mental model. The researcher interprets these based on the literature (Kane &
Trochim, 2007). This interpretation will be brought to the participants after the
conclusion of this dissertation. A session will be held to present the visual displays that
result from the concept mapping analysis and have the participants discuss them. The
goal is for participants to understand the clusters and ratings. The researcher will also
facilitate discussion of the meaning of the results and how they may help inform the
development of a pre-HCT psychosocial assessment protocol. Finally, the assessment
protocol will be developed, implemented, and tested.
In conclusion, concept mapping methodology was used to formally and
systematically identify the psychosocial elements that should be assessed in HCT
candidates, how the elements relate to one another in meaning, and how they compare to
one another in terms of their importance.
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CHAPTER IV: RESULTS

The aim of this study was to engage social workers and psychologists to
conceptualize the elements they assess in candidates for hematopoietic cell
transplantation (HCT). There were two research questions: 1) How do psychosocial
professionals conceptualize the elements they assess in candidates for hematopoietic cell
transplantation? and 2) Is there a difference in the conceptualization based on the use of
standardized risk rating scales in clinical practice? Findings related to these questions
will be discussed in this chapter.
Participants
A questionnaire (available in Appendix A) was administered to participants to
gather personal characteristics and information related to their professional practice. Due
to constraints of groupwisdom™ only 5 questions could be included in the online
application. Participants (n = 27) completed these questions before the sorting and rating
activities. Participants (n = 23) completed the remaining questions via Qualtrics after they
completed the sorting and rating activities. The sample was overwhelmingly comprised
of non-Hispanic white, female social workers with a Master’s degree. One respondent
identified as Asian; one identified as male; and one identified as a psychologist with a
Ph.D.
Regarding their professional practice, participants’ years of practice experience in
HCT patients ranged from 1 – 30 years (median 5 years), 74% practiced in both inpatient
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and outpatient settings, and 26% practiced only in the outpatient setting. Almost half of
participants assessed more than 3 HCT candidates per week, while the remaining
assessed 3 or fewer per week. Regarding use of standardized risk rating scales, one-third
reported using a scale while two-thirds reported not using a scale. A majority of the
participants (83%) were members of the Association of Oncology Social Work. In terms
of practice location, geographic diversity was well-represented: Northeast (17%),
Southeast (17%), Midwest (26%), West (17%), Southwest (22%).
Generating the Ideas
The final statement set is presented in Table 2.

Table 2
Final Statement Set (N = 114)

1
2
3
4
5
6
7
8
9
10
11
12
13

Statements
Quality assessment of an HCT candidate should include their knowledge of
community resources.
Quality assessment of an HCT candidate should include their social activities.
Quality assessment of an HCT candidate should include their interests.
Quality assessment of an HCT candidate should include their goal for having a
transplant.
Quality assessment of an HCT candidate should include concerns their family
has about proceeding with transplant.
Quality assessment of an HCT candidate should include the presence of sexual
abuse.
Quality assessment of an HCT candidate should include the presence of
emotional abuse.
Quality assessment of an HCT candidate should include any impairment in
hearing.
Quality assessment of an HCT candidate should include ethnicity.
Quality assessment of an HCT candidate should include their spirituality.
Quality assessment of an HCT candidate should include their communication
preferences.
Quality assessment of an HCT candidate should include fertility preservation.
Quality assessment of an HCT candidate should include the caregiver’s
understanding of the transplant process.
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14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40

Quality assessment of an HCT candidate should include the caregiver’s
functional limitations.
Quality assessment of an HCT candidate should include a family history of noncancer chronic illness.
Quality assessment of an HCT candidate should include their adjustment to
illness.
Quality assessment of an HCT candidate should include whether or not they have
a legal will.
Quality assessment of an HCT candidate should include whether or not a powerof-attorney for finances has been appointed.
Quality assessment of an HCT candidate should include parking needs.
Quality assessment of an HCT candidate should include the quality of their
support system.
Quality assessment of an HCT candidate should include the quality of their
relationship with their spouse or partner.
Quality assessment of an HCT candidate should include use of community
resources.
Quality assessment of an HCT candidate should include legal status if the patient
is international.
Quality assessment of an HCT candidate should include their birthplace.
Quality assessment of an HCT candidate should include use of complementary
and alternative medicine.
Quality assessment of an HCT candidate should include a trauma history.
Quality assessment of an HCT candidate should include sexual health.
Quality assessment of an HCT candidate should include their coping strategies.
Quality assessment of an HCT candidate should include their coping style.
Quality assessment of an HCT candidate should include their physical
functioning.
Quality assessment of an HCT candidate should include any barriers.
Quality assessment of an HCT candidate should include their hobbies.
Quality assessment of an HCT candidate should include unmet educational needs
related to transplant.
Quality assessment of an HCT candidate should include the quality of their
relationships with transplant team members.
Quality assessment of an HCT candidate should include adherence.
Quality assessment of an HCT candidate should include their comfort level with
self-advocacy.
Quality assessment of an HCT candidate should include health literacy.
Quality assessment of an HCT candidate should include their knowledge of
supportive care options.
Quality assessment of an HCT candidate should include their motivation for
having a transplant.
Quality assessment of an HCT candidate should include their understanding of
the transplant process.
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41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71

Quality assessment of an HCT candidate should include their beliefs that guide
medical decision-making.
Quality assessment of an HCT candidate should include concerns they have
about proceeding with transplant.
Quality assessment of an HCT candidate should include the presence of physical
abuse.
Quality assessment of an HCT candidate should include changes between their
previous quality of life and current quality of life.
Quality assessment of an HCT candidate should include their health behaviors.
Quality assessment of an HCT candidate should include advance directives.
Quality assessment of an HCT candidate should include legal issues.
Quality assessment of an HCT candidate should include their use of substances.
Quality assessment of an HCT candidate should include any impairment in
vision.
Quality assessment of an HCT candidate should include their cognition.
Quality assessment of an HCT candidate should include mental status.
Quality assessment of an HCT candidate should include family substance use.
Quality assessment of an HCT candidate should include family mental health.
Quality assessment of an HCT candidate should include their mental health.
Quality assessment of an HCT candidate should include a history of significant
losses.
Quality assessment of an HCT candidate should include gender identity.
Quality assessment of an HCT candidate should include sexual orientation.
Quality assessment of an HCT candidate should include race.
Quality assessment of an HCT candidate should include their religion.
Quality assessment of an HCT candidate should include cultural traditions.
Quality assessment of an HCT candidate should include their communication
style.
Quality assessment of an HCT candidate should include languages they speak.
Quality assessment of an HCT candidate should include their learning
preferences.
Quality assessment of an HCT candidate should include their desired level of
information.
Quality assessment of an HCT candidate should include pertinent developmental
history.
Quality assessment of an HCT candidate should include their highest level of
formal education.
Quality assessment of an HCT candidate should include their plan to cover
expenses while off work.
Quality assessment of an HCT candidate should include financial concerns.
Quality assessment of an HCT candidate should include their source(s) of
income.
Quality assessment of an HCT candidate should include Veterans Administration
(VA) benefits.
Quality assessment of an HCT candidate should include a military history.
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72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96

Quality assessment of an HCT candidate should include employment status.
Quality assessment of an HCT candidate should include occupation.
Quality assessment of an HCT candidate should include use of pharmacy
assistance programs.
Quality assessment of an HCT candidate should include use of financial
assistance programs.
Quality assessment of an HCT candidate should include their mode of
transportation.
Quality assessment of an HCT candidate should include fertility concerns.
Quality assessment of an HCT candidate should include their pharmacy benefits.
Quality assessment of an HCT candidate should include their insurance coverage.
Quality assessment of an HCT candidate should include their relocation plan (if
they need to relocate).
Quality assessment of an HCT candidate should include the caregiver’s
understanding of the caregiver role.
Quality assessment of an HCT candidate should include the caregiver’s
cognition.
Quality assessment of an HCT candidate should include the degree of
cooperation among multiple caregivers to manage the schedule.
Quality assessment of an HCT candidate should include the availability of
caregiver(s).
Quality assessment of an HCT candidate should include the caregiver’s ability to
perform required tasks.
Quality assessment of an HCT candidate should include the strength of the
caregiver’s support system.
Quality assessment of an HCT candidate should include their post-discharge 24/7
caregiver plan.
Quality assessment of an HCT candidate should include the caregiver’s plan to
work vs. visit vs. stay with patient during the patient’s admission.
Quality assessment of an HCT candidate should include the caregiver’s comfort
level with self-advocacy in the medical setting.
Quality assessment of an HCT candidate should include the caregiver’s desired
level of information.
Quality assessment of an HCT candidate should include any problems the
caregiver has had with past medical providers.
Quality assessment of an HCT candidate should include the caregiver’s mental
health.
Quality assessment of an HCT candidate should include substance use by the
caregiver.
Quality assessment of an HCT candidate should include the caregiver’s physical
health.
Quality assessment of an HCT candidate should include the caregiver’s
employment.
Quality assessment of an HCT candidate should include the caregiver’s
education level.
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97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114

Quality assessment of an HCT candidate should include the caregiver’s coping
strategies.
Quality assessment of an HCT candidate should include the caregiver’s coping
ability.
Quality assessment of an HCT candidate should include their perceived level of
social support.
Quality assessment of an HCT candidate should include support system quantity.
Quality assessment of an HCT candidate should include family stressors.
Quality assessment of an HCT candidate should include family involvement.
Quality assessment of an HCT candidate should include potential health risks in
the home environment.
Quality assessment of an HCT candidate should include whether they rent vs.
own with mortgage vs. own without mortgage.
Quality assessment of an HCT candidate should include the presence of plants in
the home.
Quality assessment of an HCT candidate should include the presence of pets in
the home.
Quality assessment of an HCT candidate should include their living situation.
Quality assessment of an HCT candidate should include their strengths.
Quality assessment of an HCT candidate should include a family history of
causes of death.
Quality assessment of an HCT candidate should include a family history of
cancer.
Quality assessment of an HCT candidate should include family composition.
Quality assessment of an HCT candidate should include their perception of how
their support system has adjusted to their illness.
Quality assessment of an HCT candidate should include the impact of illness on
their significant relationships.
Quality assessment of an HCT candidate should include marital status.

Structuring the Statements
Participants sorted the statements into piles that made sense to them and then
rated each statement according to the variable importance. Specifically, participants were
asked, “In your view, how important is this item for the quality assessment of a transplant
candidate?” Likert-scale response options included “1 Relatively unimportant, 2
Somewhat important, 3 Moderately important, 4 Important, and 5 Very important.”
Mean importance ratings for the statements ranged from 1.76 to 5.0. Statement 84
“Quality assessment of an HCT candidate should include the availability of
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caregiver(s).” was rated most important at 5.00 (SD = 0). Statement 24 “Quality
assessment of an HCT candidate should include their birthplace” was rated least
important at 1.76 (SD = 0.86). Mean importance ratings for each statement are presented
in Table 3.

Table 3
Mean Ratings by Statement
Statement
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15

Quality assessment of an HCT candidate should include their
knowledge of community resources.
Quality assessment of an HCT candidate should include their
social activities.
Quality assessment of an HCT candidate should include their
interests.
Quality assessment of an HCT candidate should include their goal
for having a transplant.
Quality assessment of an HCT candidate should include concerns
their family has about proceeding with transplant.
Quality assessment of an HCT candidate should include the
presence of sexual abuse.
Quality assessment of an HCT candidate should include the
presence of emotional abuse.
Quality assessment of an HCT candidate should include any
impairment in hearing.
Quality assessment of an HCT candidate should include ethnicity.
Quality assessment of an HCT candidate should include their
spirituality.
Quality assessment of an HCT candidate should include their
communication preferences.
Quality assessment of an HCT candidate should include fertility
preservation.
Quality assessment of an HCT candidate should include the
caregiver’s understanding of the transplant process.
Quality assessment of an HCT candidate should include the
caregiver’s functional limitations.
Quality assessment of an HCT candidate should include a family
history of non-cancer chronic illness.
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Mean S.D.
rating
3.60
0.98
3.00

1.00

3.64

1.02

4.44

0.57

3.88

0.99

4.12

0.95

4.50

0.58

3.12

0.99

2.72
3.60

1.18
0.85

4.04

0.73

3.84

1.01

4.56

0.57

4.54

0.58

2.28

1.00

16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38

Quality assessment of an HCT candidate should include their
adjustment to illness.
Quality assessment of an HCT candidate should include whether
or not they have a legal will.
Quality assessment of an HCT candidate should include whether
or not a power-of-attorney for finances has been appointed.
Quality assessment of an HCT candidate should include parking
needs.
Quality assessment of an HCT candidate should include the
quality of their support system.
Quality assessment of an HCT candidate should include the
quality of their relationship with their spouse or partner.
Quality assessment of an HCT candidate should include use of
community resources.
Quality assessment of an HCT candidate should include legal
status if the patient is international.
Quality assessment of an HCT candidate should include their
birthplace.
Quality assessment of an HCT candidate should include use of
complementary and alternative medicine.
Quality assessment of an HCT candidate should include a trauma
history.
Quality assessment of an HCT candidate should include sexual
health.
Quality assessment of an HCT candidate should include their
coping strategies.
Quality assessment of an HCT candidate should include their
coping style.
Quality assessment of an HCT candidate should include their
physical functioning.
Quality assessment of an HCT candidate should include any
barriers.
Quality assessment of an HCT candidate should include their
hobbies.
Quality assessment of an HCT candidate should include unmet
educational needs related to transplant.
Quality assessment of an HCT candidate should include the
quality of their relationships with transplant team members.
Quality assessment of an HCT candidate should include
adherence.
Quality assessment of an HCT candidate should include their
comfort level with self-advocacy.
Quality assessment of an HCT candidate should include health
literacy.
Quality assessment of an HCT candidate should include their
knowledge of supportive care options.
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4.48

0.64

3.16

1.05

2.8

1.06

2.88

1.21

4.60

0.56

4.20

0.80

3.38

0.75

3.64

1.44

1.76

0.86

3.24

1.14

3.92

0.63

3.32

0.93

4.56

0.50

4.52

0.57

3.79

0.82

4.76

0.43

2.96

1.02

4.29

0.93

4.00

0.63

4.76

0.51

3.80

0.75

4.29

0.73

3.68

0.73

39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61

Quality assessment of an HCT candidate should include their
motivation for having a transplant.
Quality assessment of an HCT candidate should include their
understanding of the transplant process.
Quality assessment of an HCT candidate should include their
beliefs that guide medical decision-making.
Quality assessment of an HCT candidate should include concerns
they have about proceeding with transplant.
Quality assessment of an HCT candidate should include the
presence of physical abuse.
Quality assessment of an HCT candidate should include changes
between their previous quality of life and current quality of life.
Quality assessment of an HCT candidate should include their
health behaviors.
Quality assessment of an HCT candidate should include advance
directives.
Quality assessment of an HCT candidate should include legal
issues.
Quality assessment of an HCT candidate should include their use
of substances.
Quality assessment of an HCT candidate should include any
impairment in vision.
Quality assessment of an HCT candidate should include their
cognition.
Quality assessment of an HCT candidate should include mental
status.
Quality assessment of an HCT candidate should include family
substance use.
Quality assessment of an HCT candidate should include family
mental health.
Quality assessment of an HCT candidate should include their
mental health.
Quality assessment of an HCT candidate should include a history
of significant losses.
Quality assessment of an HCT candidate should include gender
identity.
Quality assessment of an HCT candidate should include sexual
orientation.
Quality assessment of an HCT candidate should include race.
Quality assessment of an HCT candidate should include their
religion.
Quality assessment of an HCT candidate should include cultural
traditions.
Quality assessment of an HCT candidate should include their
communication style.
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4.42

0.57

4.76

0.43

4.40

0.69

4.80

0.40

4.72

0.53

4.28

0.53

4.36

0.62

4.40

0.80

3.56

1.02

4.72

0.60

3.13

1.17

4.48

0.57

4.68

0.47

3.60

0.98

3.24

0.81

4.84

0.37

3.72

0.78

3.48

1.20

2.80

1.36

2.88
3.16

1.14
0.78

3.84

0.78

3.92

0.69

62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83

Quality assessment of an HCT candidate should include languages
they speak.
Quality assessment of an HCT candidate should include their
learning preferences.
Quality assessment of an HCT candidate should include their
desired level of information.
Quality assessment of an HCT candidate should include pertinent
developmental history.
Quality assessment of an HCT candidate should include their
highest level of formal education.
Quality assessment of an HCT candidate should include their plan
to cover expenses while off work.
Quality assessment of an HCT candidate should include financial
concerns.
Quality assessment of an HCT candidate should include their
source(s) of income.
Quality assessment of an HCT candidate should include Veterans
Administration (VA) benefits.
Quality assessment of an HCT candidate should include a military
history.
Quality assessment of an HCT candidate should include
employment status.
Quality assessment of an HCT candidate should include
occupation.
Quality assessment of an HCT candidate should include use of
pharmacy assistance programs.
Quality assessment of an HCT candidate should include use of
financial assistance programs.
Quality assessment of an HCT candidate should include their
mode of transportation.
Quality assessment of an HCT candidate should include fertility
concerns.
Quality assessment of an HCT candidate should include their
pharmacy benefits.
Quality assessment of an HCT candidate should include their
insurance coverage.
Quality assessment of an HCT candidate should include their
relocation plan (if they need to relocate).
Quality assessment of an HCT candidate should include the
caregiver’s understanding of the caregiver role.
Quality assessment of an HCT candidate should include the
caregiver’s cognition.
Quality assessment of an HCT candidate should include the
degree of cooperation among multiple caregivers to manage the
schedule.
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4.04

0.87

4.08

0.80

4.04

0.79

3.56

0.94

2.58

1.04

4.36

0.79

4.46

0.50

4.13

0.73

2.88

0.95

2.75

1.05

3.84

1.05

3.28

0.96

3.40

1.10

3.68

1.01

4.12

0.91

3.80

0.94

3.88

1.18

4.46

0.82

4.84

0.37

4.76

0.43

4.24

0.76

4.40

0.63

84
85
86
87
88

89

90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105

Quality assessment of an HCT candidate should include the
availability of caregiver(s).
Quality assessment of an HCT candidate should include the
caregiver’s ability to perform required tasks.
Quality assessment of an HCT candidate should include the
strength of the caregiver’s support system.
Quality assessment of an HCT candidate should include their
post-discharge 24/7 caregiver plan.
Quality assessment of an HCT candidate should include the
caregiver’s plan to work vs. visit vs. stay with patient during the
patient’s admission.
Quality assessment of an HCT candidate should include the
caregiver’s comfort level with self-advocacy in the medical
setting.
Quality assessment of an HCT candidate should include the
caregiver’s desired level of information.
Quality assessment of an HCT candidate should include any
problems the caregiver has had with past medical providers.
Quality assessment of an HCT candidate should include the
caregiver’s mental health.
Quality assessment of an HCT candidate should include substance
use by the caregiver.
Quality assessment of an HCT candidate should include the
caregiver’s physical health.
Quality assessment of an HCT candidate should include the
caregiver’s employment.
Quality assessment of an HCT candidate should include the
caregiver’s education level.
Quality assessment of an HCT candidate should include the
caregiver’s coping strategies.
Quality assessment of an HCT candidate should include the
caregiver’s coping ability.
Quality assessment of an HCT candidate should include their
perceived level of social support.
Quality assessment of an HCT candidate should include support
system quantity.
Quality assessment of an HCT candidate should include family
stressors.
Quality assessment of an HCT candidate should include family
involvement.
Quality assessment of an HCT candidate should include potential
health risks in the home environment.
Quality assessment of an HCT candidate should include whether
they rent vs. own with mortgage vs. own without mortgage.
Quality assessment of an HCT candidate should include the
presence of plants in the home.
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5.00

0

4.88

0.34

4.40

0.80

4.96

0.20

3.29

1.17

4.00

0.80

3.80

0.75

3.72

0.92

4.52

0.57

4.58

0.70

4.28

0.72

3.84

0.78

3.00

0.94

4.20

0.69

4.32

0.73

4.28

0.72

3.72

0.83

4.12

0.59

4.04

1.04

4.16

0.97

2.12

0.91

2.32

1.16

106 Quality assessment of an HCT candidate should include the
presence of pets in the home.
107 Quality assessment of an HCT candidate should include their
living situation.
108 Quality assessment of an HCT candidate should include their
strengths.
109 Quality assessment of an HCT candidate should include a family
history of causes of death.
110 Quality assessment of an HCT candidate should include a family
history of cancer.
111 Quality assessment of an HCT candidate should include family
composition.
112 Quality assessment of an HCT candidate should include their
perception of how their support system has adjusted to their
illness.
113 Quality assessment of an HCT candidate should include the
impact of illness on their significant relationships.
114 Quality assessment of an HCT candidate should include marital
status.

2.84

1.16

4.52

0.64

4.35

0.56

2.50

1.08

2.68

1.16

3.32

1.05

3.80

0.80

4.16

0.61

2.68

1.29

Concept Mapping Analysis
First, a similarity matrix was calculated based on the sorting data for all
participants. The possible matrix values for the statements could range from 0 to 18,
where 0 indicates that the statements were never sorted in the same pile together and 18
indicates that every participant (n = 18) sorted the statements into the same pile. A portion
of the overall similarity matrix is presented in Table 4 to illustrate this piece of the
analysis. The table shows that statements were sorted together at various frequencies. For
example, participants never sorted statement 5 “Quality assessment of an HCT candidate
should include concerns their family has about proceeding with transplant” with
statement 7 “Quality assessment of an HCT candidate should include the presence of
emotional abuse.” Therefore, the similarity matrix shows a zero. Participants sorted
statement 2 “Quality assessment of an HCT candidate should include their social
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activities” with statement 3 “Quality assessment of an HCT candidate should include
their interests” 15 times. Therefore, the similarity matrix shows a 15.
Table 4
Portion of the Overall Similarity Matrix (Illustrative Example)

Statement

1

2

3

4

5

6

7

8

2

3

2

1

0

0

0

15

2

1

3

2

1

3

1

3

2

1

9

0

0

1

0

0

0

14

0

Index
1
2

2

3

3

15

4

2

2

3

5

1

1

1

9

6

0

3

3

0

0

7

0

2

2

0

0

14

8

0

1

1

1

0

0

0

9

0

2

1

0

0

0

0

2

10

2

6

6

0

1

1

0

1

11

1

3

2

4

5

0

0

2

12

1

0

0

2

1

1

0

5

13

0

0

0

2

2

0

1

0

14

0

0

0

0

2

0

0

0

0

Multidimensional scaling (MDS) was used to analyze the similarity matrix. MDS
used a two-dimensional solution to produce x and y coordinates for each statement. A
point map was computed based on the coordinates and is presented in Figure 1. This
point map emerged after 11 iterations and had an overall stress value of 0.2914. The
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stress value indicates the degree of discrepancy (or goodness-of-fit) between the MDS
solution (distances on the point map) and the values in the original similarity matrix. A
lower stress value is desirable because it indicates better concordance. According to Kane
and Rosas (2018), typical concept mapping projects have stress values ranging from 0.10
– 0.35, which signals that the map is interpretable. In their pooled study analysis, Rosas
and Kane (2012) found that the average stress value for 69 studies was 0.28 with range:
0.17 – 0.34. This study’s stress value is therefore considered acceptable. Statement 12 is
highlighted in Figure 1 to show how the map is configured.

Figure 1. Point Map

12. Quality assessment of an
HCT candidate should include
fertility preservation.
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After the point map was configured, hierarchical cluster analysis (HCA) used
resemblance coefficients to analyze similarities among the pairs of data. The coordinates
from the MDS were used as input for the HCA, which divided the coordinates on the
point map into clusters. The clusters were labeled based on participant labels in the
sorting phase and represent the overall theme of the statements in each cluster. The final,
12-cluster solution is presented in Figure 2. The 12 clusters are Transplant Mindset,
Support System, Caregiver, Lodging and Transportation, Financial and Legal, Work,
Demographic Characteristics, Mental Health, Communication, Education and Resource
Needs, Physical Functioning, and Cognition.

Figure 2. Final Cluster Map
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Mean cluster bridging values for the final 12-cluster solution ranged from 0.06 to
0.77. Lower bridging values indicate that statements in the cluster were sorted together at
a higher rate, meaning there is greater cohesiveness among statements within the cluster.
The Caregiver cluster was the most cohesive, with a bridging value of 0.06. Higher
bridging values indicate that statements in the cluster were sorted together less often than
statements in the other clusters, meaning there is less cohesiveness among the statements
within the cluster. The Educational and Resource Needs cluster was the least cohesive,
with a bridging value of 0.77. Bridging values and the statements in each cluster are
presented in Table 5.

Table 5
Clusters, Statements, and Bridging Values

Statement

Bridging
Value

Cluster 1: Transplant Mindset
16
Quality assessment of an HCT candidate should include their
adjustment to illness.
28
Quality assessment of an HCT candidate should include their
coping strategies.
29
Quality assessment of an HCT candidate should include their
coping style.
34
Quality assessment of an HCT candidate should include the quality
of their relationships with transplant team members.
35
Quality assessment of an HCT candidate should include adherence.
36
Quality assessment of an HCT candidate should include their
comfort level with self-advocacy.
39
Quality assessment of an HCT candidate should include their
motivation for having a transplant.
42
Quality assessment of an HCT candidate should include concerns
they have about proceeding with transplant.
44
Quality assessment of an HCT candidate should include changes
between their previous quality of life and current quality of life.
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0.42
0.50
0.42
0.52
0.53
0.52
0.57
0.57
0.44

64

Quality assessment of an HCT candidate should include their
desired level of information.
108 Quality assessment of an HCT candidate should include their
strengths.
Mean Bridging Value
Cluster 2: Support System
5
Quality assessment of an HCT candidate should include concerns
their family has about proceeding with transplant.
7
Quality assessment of an HCT candidate should include the
presence of emotional abuse.
20
Quality assessment of an HCT candidate should include the quality
of their support system.
21
Quality assessment of an HCT candidate should include the quality
of their relationship with their spouse or partner.
52
Quality assessment of an HCT candidate should include family
substance use.
53
Quality assessment of an HCT candidate should include family
mental health.
99
Quality assessment of an HCT candidate should include their
perceived level of social support.
100 Quality assessment of an HCT candidate should include support
system quantity.
101 Quality assessment of an HCT candidate should include family
stressors.
102 Quality assessment of an HCT candidate should include family
involvement.
111 Quality assessment of an HCT candidate should include family
composition.
112 Quality assessment of an HCT candidate should include their
perception of how their support system has adjusted to their illness.
113 Quality assessment of an HCT candidate should include the impact
of illness on their significant relationships.
Mean Bridging Value
Cluster 3: Caregiver
13
Quality assessment of an HCT candidate should include the
caregiver’s understanding of the transplant process.
14
Quality assessment of an HCT candidate should include the
caregiver’s functional limitations.
81
Quality assessment of an HCT candidate should include the
caregiver’s understanding of the caregiver role.
82
Quality assessment of an HCT candidate should include the
caregiver’s cognition.
83
Quality assessment of an HCT candidate should include the degree
of cooperation among multiple caregivers to manage the schedule.
84
Quality assessment of an HCT candidate should include the
availability of caregiver(s).
84

0.51
0.42
0.49
0.67
1.00
0.58
0.55
0.78
0.78
0.52
0.58
0.55
0.62
0.75
0.52
0.51
0.64
0.13
0.09
0.02
0.01
0.01
0.11

85

Quality assessment of an HCT candidate should include the
caregiver’s ability to perform required tasks.
86
Quality assessment of an HCT candidate should include the strength
of the caregiver’s support system.
87
Quality assessment of an HCT candidate should include their postdischarge 24/7 caregiver plan.
88
Quality assessment of an HCT candidate should include the
caregiver’s plan to work vs. visit vs. stay with patient during the
patient’s admission.
89
Quality assessment of an HCT candidate should include the
caregiver’s comfort level with self-advocacy in the medical setting.
90
Quality assessment of an HCT candidate should include the
caregiver’s desired level of information.
91
Quality assessment of an HCT candidate should include any
problems the caregiver has had with past medical providers.
92
Quality assessment of an HCT candidate should include the
caregiver’s mental health.
93
Quality assessment of an HCT candidate should include substance
use by the caregiver.
94
Quality assessment of an HCT candidate should include the
caregiver’s physical health.
95
Quality assessment of an HCT candidate should include the
caregiver’s employment.
96
Quality assessment of an HCT candidate should include the
caregiver’s education level.
97
Quality assessment of an HCT candidate should include the
caregiver’s coping strategies.
98
Quality assessment of an HCT candidate should include the
caregiver’s coping ability.
Mean Bridging Value
Cluster 4: Lodging and Transportation
19
Quality assessment of an HCT candidate should include parking
needs.
76
Quality assessment of an HCT candidate should include their mode
of transportation.
80
Quality assessment of an HCT candidate should include their
relocation plan (if they need to relocate).
103 Quality assessment of an HCT candidate should include potential
health risks in the home environment.
105 Quality assessment of an HCT candidate should include the
presence of plants in the home.
106 Quality assessment of an HCT candidate should include the
presence of pets in the home.
Mean Bridging Value
Cluster 5: Financial and Legal
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0
0.03
0.27
0.01
0.01
0.06
0.19
0.01
0.01
0.06
0.06
0.09
0.06
0.01
0.06
0.57
0.59
0.58
0.63
0.59
0.52
0.58

17

Quality assessment of an HCT candidate should include whether or
not they have a legal will.
18
Quality assessment of an HCT candidate should include whether or
not a power-of-attorney for finances has been appointed.
46
Quality assessment of an HCT candidate should include advance
directives.
67
Quality assessment of an HCT candidate should include their plan
to cover expenses while off work.
68
Quality assessment of an HCT candidate should include financial
concerns.
69
Quality assessment of an HCT candidate should include their
source(s) of income.
70
Quality assessment of an HCT candidate should include Veterans
Administration (VA) benefits.
74
Quality assessment of an HCT candidate should include use of
pharmacy assistance programs.
75
Quality assessment of an HCT candidate should include use of
financial assistance programs.
78
Quality assessment of an HCT candidate should include their
pharmacy benefits.
79
Quality assessment of an HCT candidate should include their
insurance coverage.
104 Quality assessment of an HCT candidate should include whether
they rent vs. own with mortgage vs. own without mortgage.
Mean Bridging Value
Cluster 6: Work
23
Quality assessment of an HCT candidate should include legal status
if the patient is international.
72
Quality assessment of an HCT candidate should include
employment status.
73
Quality assessment of an HCT candidate should include occupation.
Mean Bridging Value
Cluster 7: Demographic Characteristics
8
Quality assessment of an HCT candidate should include any
impairment in hearing.
9
Quality assessment of an HCT candidate should include ethnicity.
24
Quality assessment of an HCT candidate should include their
birthplace.
49
Quality assessment of an HCT candidate should include any
impairment in vision.
56
Quality assessment of an HCT candidate should include gender
identity.
57
Quality assessment of an HCT candidate should include sexual
orientation.
58
Quality assessment of an HCT candidate should include race.
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0.71
0.51
0.77
0.30
0.23
0.34
0.39
0.24
0.24
0.31
0.24
0.45
0.39
0.65
0.53
0.62
0.60
0.56
0.34
0.46
0.50
0.37
0.40
0.34

59

Quality assessment of an HCT candidate should include their
religion.
62
Quality assessment of an HCT candidate should include languages
they speak.
71
Quality assessment of an HCT candidate should include a military
history.
114 Quality assessment of an HCT candidate should include marital
status.
Mean Bridging Value
Cluster 8: Mental Health
6
Quality assessment of an HCT candidate should include the
presence of sexual abuse.
26
Quality assessment of an HCT candidate should include a trauma
history.
43
Quality assessment of an HCT candidate should include the
presence of physical abuse.
48
Quality assessment of an HCT candidate should include their use of
substances.
54
Quality assessment of an HCT candidate should include their
mental health.
55
Quality assessment of an HCT candidate should include a history of
significant losses.
Mean Bridging Value
Cluster 9: Communication
2
Quality assessment of an HCT candidate should include their social
activities.
3
Quality assessment of an HCT candidate should include their
interests.
4
Quality assessment of an HCT candidate should include their goal
for having a transplant.
11
Quality assessment of an HCT candidate should include their
communication preferences.
32
Quality assessment of an HCT candidate should include their
hobbies.
38
Quality assessment of an HCT candidate should include their
knowledge of supportive care options.
41
Quality assessment of an HCT candidate should include their beliefs
that guide medical decision-making.
61
Quality assessment of an HCT candidate should include their
communication style.
63
Quality assessment of an HCT candidate should include their
learning preferences.
Mean Bridging Value
Cluster 10: Educational and Resource Needs
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0.56
0.40
0.54
0.61
0.46
0.54
0.53
0.59
0.57
0.51
0.52
0.54
0.51
0.51
0.53
0.55
0.53
0.64
0.61
0.50
0.54
0.55

1

Quality assessment of an HCT candidate should include their
knowledge of community resources.
15
Quality assessment of an HCT candidate should include a family
history of non-cancer chronic illness.
22
Quality assessment of an HCT candidate should include use of
community resources.
31
Quality assessment of an HCT candidate should include any
barriers.
33
Quality assessment of an HCT candidate should include unmet
educational needs related to transplant.
37
Quality assessment of an HCT candidate should include health
literacy.
40
Quality assessment of an HCT candidate should include their
understanding of the transplant process.
45
Quality assessment of an HCT candidate should include their health
behaviors.
109 Quality assessment of an HCT candidate should include a family
history of causes of death.
Mean Bridging Value
Cluster 11: Physical Functioning
12
Quality assessment of an HCT candidate should include fertility
preservation.
25
Quality assessment of an HCT candidate should include use of
complementary and alternative medicine.
30
Quality assessment of an HCT candidate should include their
physical functioning.
47
Quality assessment of an HCT candidate should include legal
issues.
66
Quality assessment of an HCT candidate should include their
highest level of formal education.
77
Quality assessment of an HCT candidate should include fertility
concerns.
107 Quality assessment of an HCT candidate should include their living
situation.
110 Quality assessment of an HCT candidate should include a family
history of cancer.
Mean Bridging Value
Cluster 12: Cognition
10
Quality assessment of an HCT candidate should include their
spirituality.
27
Quality assessment of an HCT candidate should include sexual
health.
50
Quality assessment of an HCT candidate should include their
cognition.
51
Quality assessment of an HCT candidate should include mental
status.
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0.86
0.72
0.76
0.96
0.77
0.66
0.67
0.82
0.74
0.77
0.67
0.64
0.51
0.83
0.65
0.60
0.90
0.67
0.68
0.66
0.59
0.61
0.58

60
65

Quality assessment of an HCT candidate should include cultural
traditions.
Quality assessment of an HCT candidate should include pertinent
developmental history.
Mean Bridging Value

0.63
0.64
0.62

The Cluster Bridging Map is presented in Figure 3. The mean bridging values are
displayed in the third dimension; the fewer levels a cluster has, the more cohesive it is
relative to the other clusters.

Figure 3. Cluster Bridging Map

Item and Cluster Ratings Analyses
Ratings data were analyzed from the 24 participants who participated in this phase
of the study. Participants rated each statement according to their view of how important it
was in the quality assessment of a transplant candidate. Figure 4 is a Point Rating Map
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that uses the Point Map in Figure 1 to visually depict the ratings data for each statement.
The number of layers in the column’s height indicates the mean importance. For example,
statement 87 has 5 layers, which indicates the highest level of importance. Many
statements with 5 layers are located at the top of the map and in the lower right corner.
Figure 4. Point Rating Map

87. Quality assessment
of an HCT candidate
should include their
post-discharge 24/7
caregiver plan.
The Cluster Rating Map in Figure 5 depicts the mean importance rating of all
statements in each cluster. The more layers a cluster has, the higher average importance
the statements in that cluster had relative to the other clusters. The Transplant Mindset,
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Caregiver, and Mental Health clusters have 5 layers, which indicates the highest level of
importance. Conversely, the Demographic Characteristics cluster has only 1 layer, which
indicates that statements in the cluster were rated the least important.

Figure 5. Cluster Rating Map

Group Differences
A pattern match was used to explore differences between participants who use
standardized psychosocial risk rating tools in their practice and those who do not. This
analysis compared cluster importance ratings between the two groups. Of the 24
participants who provided ratings data, 8 used a standardized psychosocial risk rating tool
and 16 did not. The pattern match is presented in Figure 6.
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Figure 6. Pattern Match

r = 0.91
The 3 highest rated clusters for both groups were Transplant Mindset, Caregiver,
and Mental Health, while the lowest rated cluster for both groups was Demographic
Characteristics. The correlation statistic for all cluster ratings was high (r = 0.91).
Welch’s t-tests were used to examine differences between the two groups in mean
ratings for each cluster. For the Transplant Mindset cluster, the mean rating among
participants who do not rate risk was 4.34 (SD = 0.10), and the mean rating among those
who do was 4.35 (SD = 0.11). Results from a t-test showed no significant difference
between these mean ratings (t(20) = 0.07, p = 0.94). For the Support System cluster, the
mean rating among participants who do not rate risk was 3.95 (SD = 0.19), and the mean
rating among those who do was 3.88 (SD = 0.16). Results from a t-test showed no
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significant difference between these mean ratings (t(24) = 0.44, p = 0.67). For the
Caregiver cluster, the mean rating among participants who do not rate risk was 4.20 (SD
= 0.27), and the mean rating among those who do was 4.32 (SD = 0.38). Results from a ttest showed no significant difference between these mean ratings (t(38) = 0.68, p = 0.50).
For the Lodging and Transportation cluster, the mean rating among participants
who do not rate risk was 3.56 (SD = 0.72), and the mean rating among those who do was
3.35 (SD = 1.09). Results from a t-test showed no significant difference between these
mean ratings (t(10) = 0.38, p = 0.71). For the Financial and Legal cluster, the mean rating
among participants who do not rate risk was 3.68 (SD = 0.67), and the mean rating
among those who do was 3.56 (SD = 0.83). Results from a t-test showed no significant
difference between these mean ratings (t(19) = 0.31, p = 0.76). For the Work cluster, the
mean rating among participants who do not rate risk was 3.48 (SD = 0.07), and the mean
rating among those who do was 3.63 (SD = 0.07). Results from a t-test showed no
significant difference between these mean ratings (t(4) = 0.68, p = 0.54).
For the Demographic Characteristics cluster, the mean rating among participants
who do not rate risk was 2.85 (SD = 0.35), and the mean rating among those who do was
3.01 (SD = 0.23). Results from a t-test showed no significant difference between these
mean ratings (t(20) = 0.72, p = 0.48). For the Mental Health cluster, the mean rating
among participants who do not rate risk was 4.33 (SD = 0.18), and the mean rating
among those who do was 4.29 (SD = 0.31). Results from a t-test showed no significant
difference between these mean ratings (t(10) = 0.15, p = 0.89). For the Communication
cluster, the mean rating among participants who do not rate risk was 3.68 (SD = 0.28),
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and the mean rating among those who do was 3.93 (SD = 0.35). Results from a t-test
showed no significant difference between these mean ratings (t(16) = 0.94, p = 0.36).
For the Educational and Resource Needs cluster, the mean rating among
participants who do not rate risk was 3.89 (SD = 0.81), and the mean rating among those
who do was 3.56 (SD = 0.83). Results from a t-test showed no significant difference
between these mean ratings (t(16) = 0.77, p = 0.45). For the Physical Functioning cluster,
the mean rating among participants who do not rate risk was 3.48 (SD = 0.07), and the
mean rating among those who do was 3.38 (SD = 0.43). Results from a t-test showed no
significant difference between these mean ratings (t(9) = 0.38, p = 0.71). For the Cognition
cluster, the mean rating among participants who do not rate risk was 3.91 (SD = 0.29),
and the mean rating among those who do was 3.85 (SD = 0.23). Results from a t-test
showed no significant difference between these mean ratings (t(10) = 0.18, p = 0.86).
Go-Zone Graphs. Go-zone graphs are bivariate graphs produced for each cluster.
They are divided into quadrants according to the mean importance ratings for the two
groups: participants who use standardized psychosocial risk rating scales and participants
who do not. Statements in the right upper quadrant (referred to as the Go-Zone) rate
above the cluster’s mean importance rating for both groups, while statements in the lower
left quadrant rate below the mean for both groups. Statements in the upper left quadrant
were rated above the mean only by participants who use risk ratings, and statements in
the lower right quadrant were rated above the mean only by participants who do not use
risk ratings. Figures 7 – 18 present the go-zone graphs for the 12 clusters in the final
solution.
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Figure 7. Transplant Mindset Cluster Go-Zone Graph

The five statements in the Go-Zone (upper right quadrant) of the Transplant Mindset
cluster include: 16 Quality assessment of an HCT candidate should include their
adjustment to illness, 28 Quality assessment of an HCT candidate should include their
coping strategies, 29 Quality assessment of an HCT candidate should include their coping
style, 35 Quality assessment of an HCT candidate should include adherence, and 42
Quality assessment of an HCT candidate should include concerns they have about
proceeding with transplant. Five statements rated below the mean for both groups and are
in the lower left quadrant: 34 Quality assessment of an HCT candidate should include the
quality of their relationships with transplant team members, 44 Quality assessment of an
HCT candidate should include changes between their previous quality of life and current
quality of life, 64 Quality assessment of an HCT candidate should include their desired
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level of information, and 108 Quality assessment of an HCT candidate should include
their strengths.

Figure 8. Support System Cluster Go-Zone Graph

Statements in the Go-Zone of the Support System Cluster include: 7 Quality assessment
of an HCT candidate should include the presence of emotional abuse, 20 Quality
assessment of an HCT candidate should include the quality of their support system, 21
Quality assessment of an HCT candidate should include the quality of their relationship
with their spouse or partner, 99 Quality assessment of an HCT candidate should include
their perceived level of social support, 102 Quality assessment of an HCT candidate
should include family involvement, and 113 Quality assessment of an HCT candidate
should include the impact of illness on their significant relationships. Statements that
were rated below the mean by both groups include: 52 Quality assessment of an HCT
candidate should include family substance use, 53 Quality assessment of an HCT
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candidate should include family mental health, 100 Quality assessment of an HCT
candidate should include support system quantity, 111 Quality assessment of an HCT
candidate should include family composition, and 112 Quality assessment of an HCT
candidate should include their perception of how their support system has adjusted to
their illness.

Figure 9. Caregiver Cluster Go-Zone Graph

Statements in the Go-Zone of the Caregiver Cluster include: 13 Quality assessment of an
HCT candidate should include the caregiver’s understanding of the transplant process, 14
Quality assessment of an HCT candidate should include the caregiver’s functional
limitations, 81 Quality assessment of an HCT candidate should include the caregiver’s
understanding of the caregiver role, 84 Quality assessment of an HCT candidate should
include the availability of caregiver(s), 85 Quality assessment of an HCT candidate
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should include the caregiver’s ability to perform required tasks, 87 Quality assessment of
an HCT candidate should include their post-discharge 24/7 caregiver plan, 92 Quality
assessment of an HCT candidate should include the caregiver’s mental health, and 93
Quality assessment of an HCT candidate should include substance use by the caregiver.
Statements that were rated below the mean by both groups include: 88 Quality
assessment of an HCT candidate should include the caregiver’s plan to work vs. visit vs.
stay with patient during the patient’s admission, 89 Quality assessment of an HCT
candidate should include the caregiver’s comfort level with self-advocacy in the medical
setting, 90 Quality assessment of an HCT candidate should include the caregiver’s
desired level of information, 91 Quality assessment of an HCT candidate should include
any problems the caregiver has had with past medical providers, 95 Quality assessment of
an HCT candidate should include the caregiver’s employment, and 96 Quality assessment
of an HCT candidate should include the caregiver’s education level.
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Figure 10. Lodging and Transportation Cluster Go-Zone Graph

Statements in the Lodging and Transportation cluster that were rated above the mean by
both groups and therefore fall in the Go-Zone include: 76 Quality assessment of an HCT
candidate should include their mode of transportation, 80 Quality assessment of an HCT
candidate should include their relocation plan (if they need to relocate), and 103 Quality
assessment of an HCT candidate should include potential health risks in the home
environment. Statements in the Lodging and Transportation cluster that were rated below
the mean by both groups include: 19 Quality assessment of an HCT candidate should
include parking needs, 105 Quality assessment of an HCT candidate should include the
presence of plants in the home, and 106 Quality assessment of an HCT candidate should
include the presence of pets in the home.
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Figure 11. Financial and Legal Cluster Go-Zone Graph

Statements in the Financial and Legal cluster are located in the Go-Zone include:
46 Quality assessment of an HCT candidate should include advance directives, 67
Quality assessment of an HCT candidate should include their plan to cover expenses
while off work, 68 Quality assessment of an HCT candidate should include financial
concerns, 69 Quality assessment of an HCT candidate should include their source(s) of
income, 78 Quality assessment of an HCT candidate should include their pharmacy
benefits, and 79 Quality assessment of an HCT candidate should include their insurance
coverage.
Statements in the Financial and Legal cluster that were rated below the mean by
both groups include: 17 Quality assessment of an HCT candidate should include whether
or not they have a legal will, 18 Quality assessment of an HCT candidate should include
whether or not a power-of-attorney for finances has been appointed, 70 Quality
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assessment of an HCT candidate should include Veterans Administration (VA) benefits,
74 Quality assessment of an HCT candidate should include use of pharmacy assistance
programs, and 104 Quality assessment of an HCT candidate should include whether they
rent vs. own with mortgage vs. own without mortgage.

Figure 12. Work Cluster Go-Zone Graph

The statement in the Work cluster that is located in the Go-Zone is 72 Quality
assessment of an HCT candidate should include employment status. The statement that
both groups rated below the mean is 73 Quality assessment of an HCT candidate should
include occupation.
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Figure 13. Demographic Characteristics Cluster Go-Zone Graph

Statements in the Demographic Characteristics cluster that are located in the GoZone include: 8 Quality assessment of an HCT candidate should include any impairment
in hearing, 56 Quality assessment of an HCT candidate should include gender identity, 59
Quality assessment of an HCT candidate should include their religion, and 62 Quality
assessment of an HCT candidate should include languages they speak. Statements in the
Demographic Characteristics cluster that were rated below the mean by both groups
include: 9 Quality assessment of an HCT candidate should include ethnicity, 24 Quality
assessment of an HCT candidate should include their birthplace, 57 Quality assessment
of an HCT candidate should include sexual orientation, 58 Quality assessment of an HCT
candidate should include race, 71 Quality assessment of an HCT candidate should include
a military history, and 114 Quality assessment of an HCT candidate should include
marital status.

102

Figure 14. Mental Health Cluster Go-Zone Report

Statements in the Mental Health cluster that are located in the Go-Zone include:
43 Quality assessment of an HCT candidate should include the presence of physical
abuse, 48 Quality assessment of an HCT candidate should include their use of substances,
and 54 Quality assessment of an HCT candidate should include their mental health.
Statements that were rated below the mean by both groups include: 6 Quality assessment
of an HCT candidate should include the presence of sexual abuse, 26 Quality assessment
of an HCT candidate should include a trauma history, and 55 Quality assessment of an
HCT candidate should include a history of significant losses.
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Figure 15. Communication Cluster Go-Zone Graph

Statements in the Communication cluster that were rated above the mean by both
groups include: 4 Quality assessment of an HCT candidate should include their goal for
having a transplant, 11 Quality assessment of an HCT candidate should include their
communication preferences, 41 Quality assessment of an HCT candidate should include
their beliefs that guide medical decision-making, and 61 Quality assessment of an HCT
candidate should include their communication style. Statements in the Communication
cluster that were rated below the mean by both groups include: 2 Quality assessment of
an HCT candidate should include their social activities, and 32 Quality assessment of an
HCT candidate should include their hobbies.
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Figure 16: Educational and Resource Needs Cluster Go-Zone Graph

Statements in the Educational and Resource Needs cluster that were rated above
the mean by both groups include: 31 Quality assessment of an HCT candidate should
include any barriers, 33 Quality assessment of an HCT candidate should include unmet
educational needs related to transplant, 37 Quality assessment of an HCT candidate
should include health literacy, 40 Quality assessment of an HCT candidate should include
their understanding of the transplant process, and 45 Quality assessment of an HCT
candidate should include their health behaviors.
Statements in the Educational and Resource Needs cluster that were rated below
the mean by both groups include: 1 Quality assessment of an HCT candidate should
include their knowledge of community resources, 15 Quality assessment of an HCT
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candidate should include a family history of non-cancer chronic illness, 22 Quality
assessment of an HCT candidate should include use of community resources, and 109
Quality assessment of an HCT candidate should include a family history of causes of
death.

Figure 17. Physical Functioning Cluster Go-Zone Graph

Statements in the Physical Functioning cluster that fell in the Go-Zone include:
30 Quality assessment of an HCT candidate should include their physical functioning, 77
Quality assessment of an HCT candidate should include fertility concerns, 107 Quality
assessment of an HCT candidate should include their living situation. Statements in the
Physical Functioning cluster that were rated below the mean by both groups include: 25
Quality assessment of an HCT candidate should include use of complementary and
alternative medicine, 66 Quality assessment of an HCT candidate should include their
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highest level of formal education, 110 Quality assessment of an HCT candidate should
include a family history of cancer.

Figure 18. Cognition Cluster Go-Zone Graph

Statements in the Cognition cluster that fall in the Go-Zone include: 50 Quality
assessment of an HCT candidate should include their cognition, and 51 Quality
assessment of an HCT candidate should include mental status. Statements in the
Cognition cluster that were rated by both groups below the mean include: 10 Quality
assessment of an HCT candidate should include their spirituality, 27 Quality assessment
of an HCT candidate should include sexual health, 60 Quality assessment of an HCT
candidate should include cultural traditions, 65 Quality assessment of an HCT candidate
should include pertinent developmental history.
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CHAPTER V: DISCUSSION AND CONCLUSIONS

This chapter will offer an interpretation of the results presented in the previous
chapter. It will also offer implications for practice, policy, workforce training, and
research. Since concept mapping is a multi-step process, results from each step will be
discussed in turn. Even so, the results can only be fully understood in the context of the
overall analyses. The data must be taken together, critically examined, and interpreted as
a whole in the context of the study.

Map Interpretations
The final solution contained 12 clusters. Based on the bridging values, the
Caregiver cluster was the most cohesive. This means that participants sorted the
statements in this cluster together at a higher rate than they sorted the statements in any
other cluster. In order of most to least cohesive, the Caregiver cluster was followed by
Financial and Legal, Demographic Characteristics, Transplant Mindset, Mental Health,
Communication, Lodging and Transportation, Work, Cognition, Support System, Physical
Functioning, and Educational and Resource Needs. The Educational and Resources
Needs cluster was the least cohesive. Its position in the center of the map reflects this,
since comparatively, the statements in the cluster were more frequently sorted with
statements in clusters around the map.
Statement Interpretations
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Convergence with the literature. The statements that were brainstormed in this
study capture ideas that are present in the literature. Overall, the statements cover all of
the elements listed in the PACT, SIPAT, and TERS. One exception is the SIPAT item
“effect of truthfulness vs. deceptive behavior in presentation” that asks the professional to
evaluate the degree to which the patient has been “forthcoming with negative
information.” The profession of social work endorses a strengths-based perspective.
Statement 108 Quality assessment of an HCT candidate should include their strengths
captures this idea.
The AOSW standards for psychosocial assessment lists “barriers to care” as one
of 8 areas that should be assessed. This idea is captured in statement 31. Quality
assessment of an HCT candidate should include any barriers. This statement was rated
4.76 and had a bridging value of 0.43. Thus, while participants considered this element
highly important, they ascribed different meanings to it in relation to the other elements.
The AOSW standards also list assessment of physical disability, which is reflected in the
following statements: 8. Quality assessment of an HCT candidate should include any
impairment in hearing, 30. Quality assessment of an HCT candidate should include their
physical functioning, and 49. Quality assessment of an HCT candidate should include any
impairment in vision.
Furthermore, the AOSW standards include assessment of “race, ethnicity, religion,
culture, language, physical or mental disability, socioeconomic status, sexual orientation,
and gender identity,” which are all represented in the brainstormed statements.
Socioeconomic status is generally considered a measure of class standing that can be
measured by factors such as income, occupation, and education level. These elements are
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reflected in the following statements: 69. Quality assessment of an HCT candidate should
include their source(s) of income, 72. Quality assessment of an HCT candidate should
include employment status, 73. Quality assessment of an HCT candidate should include
occupation, and 66. Quality assessment of an HCT candidate should include their highest
level of formal education.
The substantial and growing body of literature on HCT caregivers acknowledges
that they are significantly impacted by the transplant process and in need of assessment
and interventions to promote their own well-being. This is strongly emphasized in the
brainstormed statements. Of the 114 statements, 20 of them specifically mentioned the
caregiver. This reflects more than a brief screening. The 20 items constitute a full
assessment of the caregiver. This level of attention is congruent with the substantial body
of literature on the role, experience, and variety of outcomes of HCT caregivers.
The psychosocial risk rating tools applied to HCT rate the family or support
system in terms of availability, quality, stability, functionality, mental health, and
substance use. These ideas are captured in the brainstormed statements: 6. Quality
assessment of an HCT candidate should include the presence of sexual abuse, 7. Quality
assessment of an HCT candidate should include the presence of emotional abuse, 20.
Quality assessment of an HCT candidate should include the quality of their support
system, 21. Quality assessment of an HCT candidate should include the quality of their
relationship with their spouse or partner, 43. Quality assessment of an HCT candidate
should include the presence of physical abuse, 52. Quality assessment of an HCT
candidate should include family substance use, 53. Quality assessment of an HCT
candidate should include family mental health, 99. Quality assessment of an HCT
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candidate should include their perceived level of social support, 100. Quality assessment
of an HCT candidate should include support system quantity, 101. Quality assessment of
an HCT candidate should include family stressors, 102. Quality assessment of an HCT
candidate should include family involvement, 111. Quality assessment of an HCT
candidate should include family composition, 112. Quality assessment of an HCT
candidate should include their perception of how their support system has adjusted to
their illness, and 113. Quality assessment of an HCT candidate should include the impact
of illness on their significant relationships.
Another area of convergence between the literature and the statements is fertility
and sexual health. Outcomes literature identifies fertility and sexual concerns as common
and enduring aspects of post-transplant life. Fertility and sexual concerns do not appear in
the literature on psychosocial risk since they are not considered risk factors for poorer
survival. Yet, participants identified that these areas should be assessed and addressed
pre-transplant as evidenced by the following statements: 12. Quality assessment of an
HCT candidate should include fertility preservation, 27. Quality assessment of an HCT
candidate should include their sexual health, and 77. Quality assessment of an HCT
candidate should include fertility concerns.
Assessing the patient’s knowledge and understanding of their diagnosis and the
proposed treatment is ubiquitous in conceptualizations of psychosocial elements that
should be assessed prior to planned, intensive medical interventions. The patient’s desire
for the medical intervention as well as cognition/mental status are also present in
conceptualizations, but to a slightly lesser degree. These ideas relate to the ethical
principle of informed consent for medical treatment. Upholding the principle of informed
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consent requires two preconditions: competence to understand and choose and
voluntariness (no coercion) in choosing (Beauchamp & Childress, 2013). It also requires
that providers disclose information about the diagnosis, all reasonable treatment options,
and the potential risks and benefits of those options. Additionally, providers must check
for understanding of this information (Beauchamp & Childress, 2013).
Dew et al. (2000), writing in the context of solid organ transplantation,
recommend that “mental (cognitive) status should routinely be included in the
psychosocial evaluation, because cognitive status will affect patients’ ability to
understand the transplant experience and provide informed consent, as well as
comprehend what is required of them” (p. 241). Informed consent is strongly emphasized
in the conceptualization of psychosocial elements that should be assessed in candidates
for experimental spinal cord injury, because the treatment is experimental. Even though
HCT is now a standard therapy for many diseases, patients are often offered the
opportunity to participate in research studies. According to Raj et al. (2017), patients may
be asked to participate in up to 10 studies, each with lengthy consent documents. This can
understandably be overwhelming and add stress when patients and their caregivers are
already feeling distressed and vulnerable. Accordingly, ensuring understanding, clear
communication, and voluntariness is all the more important.
Fifteen statements reflect aspects of informed consent: 4. Quality assessment of
an HCT candidate should include their goal for having a transplant, 11. Quality
assessment of an HCT candidate should include their communication preferences, 33.
Quality assessment of a transplant candidate should include any unmet educational
needs, 36. Quality assessment of an HCT candidate should include their comfort level
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with self-advocacy, 37. Quality assessment of an HCT candidate should include health
literacy, 38. Quality assessment of an HCT candidate should include their knowledge of
supportive care options, 39. Quality assessment of an HCT candidate should include their
motivation for having a transplant, 41. Quality assessment of an HCT candidate should
include their beliefs that guide medical decision-making, 42. Quality assessment of an
HCT candidate should include concerns they have about proceeding with transplant, 50.
Quality assessment of an HCT candidate should include their cognition, 51. Quality
assessment of an HCT candidate should include mental status, 61. Quality assessment of
an HCT candidate should include their communication style, 63. Quality assessment of
an HCT candidate should include their learning preferences, 64. Quality assessment of
an HCT candidate should include their desired level of information, and 65. Quality
assessment of an HCT candidate should include pertinent developmental history. These
statements clearly demonstrate that participants consider supporting the patient’s
informed decision-making is one purpose of their assessment. This purpose is less wellrecognized than other purposes but should not be overlooked.
Participants’ ideas also reflected aspects of informed consent with the caregiver:
13. Quality assessment of an HCT candidate should include the caregiver’s
understanding of the transplant process, 81. Quality assessment of an HCT candidate
should include the caregiver’s understanding of the caregiver role, 82. Quality
assessment of an HCT candidate should include the caregiver’s cognition, 89. Quality
assessment of an HCT candidate should include the caregiver’s comfort level with selfadvocacy in the medical setting, and 90. Quality assessment of an HCT candidate should
include the caregiver’s desired level of information.
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Finally, the financial impact of HCT was apparent in the statements and accords
with literature regarding the financial consequences of HCT. Participants brainstormed 11
ideas that address financial status, needs, and use of assistance programs. This reflects a
comprehensive financial assessment. It also connects with a previous finding in the
literature that social workers rated resolving financial barriers for uninsured or
underinsured patients as one of their most common challenges (Stickney Ferguson et al.,
2018). Examples of statements related to finances include 18. Quality assessment of an
HCT candidate should include whether or not a power-of-attorney for finances has been
appointed, 68. Quality assessment of an HCT candidate should include financial
concerns, 74. Quality assessment of an HCT candidate should include use of pharmacy
assistance programs, and 79. Quality assessment of an HCT candidate should include
their insurance coverage.
Divergence with the literature. One major divergence between the ideas
gathered and the empirical literature is regarding the construct of psychosocial distress.
Distress is a prominent construct in the literature but does not appear in the statement list.
The term distress was selected by a National Comprehensive Cancer Network panel that
introduced clinical management guidelines for it in 1997. The term was selected because
it was thought to be more acceptable and less stigmatizing than terms such as psychiatric,
psychosocial, or emotional (National Comprehensive Cancer Network, 2021). In 2015,
the American College of Surgeon’s Commission on Cancer mandated that accredited
cancer centers screen all patients for psychosocial distress. This resulted in a boon for
research on the prevalence and sources of distress as well as screening and program
implementation.
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The National Comprehensive Cancer Network’s widely used definition of
psychosocial distress is “a multifactorial unpleasant experience of a psychological
(cognitive, behavioral, emotional), social, spiritual and/or physical nature that may
interfere with the ability to cope effectively with cancer, its physical symptoms, and its
treatment” (National Comprehensive Cancer Network, 2021). The definition also states
that distress “extends along a continuum, ranging from common normal feelings of
vulnerability, sadness, and fears to problems that can become disabling, such as
depression, anxiety, panic, social isolation, and existential and spiritual crisis” (National
Comprehensive Cancer Network, 2021). Clearly, distress is a broad, multidimensional
construct. The purpose of screening for distress is to identify patients who need more
comprehensive assessment and intervention. It is likely, then, that study participants did
not mention distress as an element that should be assessed because they were
brainstorming a comprehensive, detailed list of elements that should be assessed.
Depressive symptomatology is notable in the literature but does not specifically
appear in the statement set. It appeared in the initial brainstormed list but was synthesized
into statement 54. Quality assessment of an HCT candidate should include their mental
health along with other constructs including anxiety, suicidal ideation, obsessivecompulsive disorder, schizophrenia, eating disorder, personality disorder characteristics,
panic attacks, post-traumatic stress disorder, attention deficit and hyperactivity disorder,
history of psychiatric hospitalization and psychoactive medication. This was done out of
concern for participant burden related to the number of statements that would need to be
sorted and rated.
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Sorting Interpretations
Participants seemed to sort the statements based on the overarching theme of
capacities. Sorting according to capacities aligns the purpose of psychosocial assessment
to “identify the individual’s capacity to deal with negative or positive consequences of
[transplant] (Fronek, 2004, p. 6). Dictionary definitions of capacity lend richer
description to this idea: a person’s ability to do a specific thing, the maximum amount
that can be received or contained, the actual or potential ability to withstand or perform,
the quality or state of being susceptible to a specific treatment or action (Dictionary.com,
2021). Psychosocial professionals in HCT are assessing the patient’s and caregiver’s
ability to withstand the arduous transplant process. Do they have what it takes? What will
help them and what will hinder them?
Perhaps the most interesting cluster is the Caregiver cluster. The Caregiver cluster
included the most statements (n = 20) of any cluster and was by far the most cohesive
with a bridging value of 0.06. Participants viewed the caregiver as conceptually distinct
from the broader support system and elevated its importance with a mean rating of 4.24
compared to 3.92 for the Support System cluster. This reinforces the attention that the
outcomes literature pays to caregivers. Interestingly, the vast majority of the literature
that examines associations between pre-HCT psychosocial factors and post-HCT
outcomes measures family/social support but not specifically the caregiver. This is likely
due to the research using the PACT, SIPAT, and TERS. These measures ask the
psychosocial professional to rate the family/support system but not specifically the
caregiver.
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HCT is a treatment for life-threatening and life-limiting illness. HCT itself can
also be life-threatening and life-limiting. Taken together, the statements in the Transplant
Mindset cluster speak to a frame of mind or overarching approach around the intensive
treatment they are about to undergo. Statements in this cluster related to the patient’s
capacity for coping and adjustment to illness, adhering to treatment, processing
information, self-advocacy, and forming relationships with transplant team members. It
also included how their quality of life has changed, their motivation for undergoing HCT,
and concerns they have about proceeding with transplant. Statement 108. Quality
assessment of a transplant candidate should include their strengths was also sorted in this
cluster, indicating that participants viewed it as relating to the idea of an attitude,
approach, or frame of mind that would increase their capacity to handle HCT. Elements
within this cluster, such as coping and adherence, have been examined within the
literature, but the construct of a mindset towards transplant has not been conceptualized,
measured, or studied. Beeken, Eiser, & Dalley’s (2011) qualitative study touched on this
construct by identifying mechanisms that patients find helpful for adjustment such as
optimism balanced with realism; focusing on the short-term; adjusting expectations of
physical functioning; positively-interpreted comparisons to other patients, and not
thinking about their illness.
Rating Interpretations
The Pattern Match analysis showed the clusters in rank order of importance
according to two groups: participants who use standardized psychosocial risk rating
scales in their practice and those who do not. Three clusters were ranked highest by both
groups: Transplant Mindset, Caregiver, and Mental Health. The next 8 clusters ranged
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from 3.47 to 3.92 in mean importance and varied in their rank order between the two
groups. These clusters included Support System, Cognition, Educational and Resource
Needs, Communication, Financial and Legal, Work, Lodging and Transportation, and
Physical Functioning. There was high correlation between the groups’ ratings.
The high rating of the Transplant Mindset cluster aligns with theories that link
stress and adherence to disease outcomes. According to these theories, reducing the
impact of stress on the body leads to better outcomes. The elements that participants rated
above the mean importance for the cluster demonstrate this connection. Participants rated
adjustment to illness, coping strategies, coping style, adherence, and concerns the patient
has about proceeding with HCT as the highest priority for assessment in this cluster.
These elements may increase or decrease stress, thereby impacting outcomes.
Physical Functioning was rated lower in importance relative to other clusters,
suggesting that the patient’s capacity in this area is a lower priority for determining
readiness for transplant. Indeed, this study showcases that patients need far more than
physical capacities to undergo transplant. They need emotional, mental, social, and
material capacities. They also need a caregiver with emotional, mental, social, and
material capacities. Unfortunately, some centers do not have a psychosocial professional
proactively assess every patient (Randall et al., 2021).
There was clear agreement between the two groups that Demographic
Characteristics ranked the lowest in importance. The relatively low rating of
Demographic Characteristics is discordant with the priority the empirical literature
places on these factors. Of all the brainstormed statements, more is known about
demographic characteristics as risk factors for poorer survival and other outcomes than
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any other variables. One of the first things researchers consider is differences in groups
based on these variables. The participants considered these a lower priority in their
assessment. This may be due to participants viewing the items as “checkbox” information
that is mostly found in the electronic health record rather than gathered through their
clinical interview. The low ratings may also be attributed to social workers perceiving
that their interventions do not target these aspects.
Rating Differences
T-tests were performed to examine differences between mean ratings for
statements in each cluster by two groups: participants who use risk rating tools in their
practice and participants who do not use risk rating tools. There were no significant
differences in mean ratings for the two groups. This suggests that psychosocial risk rating
tools do not significantly influence the way psychosocial professionals prioritize the
importance of the elements they assess in a transplant candidate.

Summary of Interpretations
The conceptual domain of psychosocial elements that should be assessed in HCT
candidates is broad and multidimensional. The elements far exceed those that are found
in conceptualizations of psychosocial risk. The ideas were configured into 12 distinct
clusters. Psychosocial professionals seemed to organize the elements based on domains
of capacity. Ratings data showed no differences in ratings based on whether the
psychosocial professional uses a standardized risk rating scale in their practice. Ratings
data also showed that Caregiver, Transplant Mindset, and Mental Health clusters were
the highest priorities.
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Implications
The following implications arise from the study and the existing body of
literature.
Social Work Practice
Study findings offer HCT social workers and psychologists a conceptualization of
the psychosocial elements that is not limited to “risk factors” and that was created from
their own voices and knowledge. Pre-HCT psychosocial assessment should include all
domains of capacity as conceptualized by the participants and give highest priority to
patients’ mental health, mindset about transplant, and the caregiver. The statements and
resulting clusters can be considered a comprehensive picture of the pre-HCT
psychosocial assessment. Psychosocial professionals can compare their current practice
to it and identify opportunities to align their practice.
The conceptualization will inform the creation of a psychosocial assessment
protocol. The findings suggest implications for the protocol. First, the clusters may
provide an organizational structure for the overarching domains that should be assessed.
Second, elements that fell in the go-zones should be given higher priority for assessment.
Time can be limited in the dynamic, too-often crisis-oriented setting of HCT. When the
ideal amount of time for assessment is not available, psychosocial professionals needs to
focus on the most important elements. The go-zone graphs can inform these.
Third, given how challenged the empirical literature is by inconsistent and poor
quality measurement, a protocol should specify variables to measure with standardized
instruments that have strong psychometric properties. Only 1-2 should be administered in
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order to minimize burden (Austin & Rini, 2013). Therefore, priority constructs need to be
identified. The conceptual framework suggests that variables within mental health,
transplant mindset, and the caregiver should be considered. Lastly, the protocol needs to
include methods to collect accurate demographic data, because these data are essential for
conducting high quality research.
One clear practice implication of the conceptual framework is that assessing the
patient includes thoroughly assessing the caregiver. Given their vital importance, the
caregiver should be considered as much the social worker’s client as the patient. Social
workers should offer programs and interventions to promote caregivers’ well-being.
Many centers already offer support groups and other psychosocial care services to
caregivers. Those that do not should prioritize implementing such programs.
The NASW Code of Ethics mandates social workers to “critically examine and
keep current with emerging knowledge relevant to social work and fully use…research
evidence in their professional practice” (National Association of Social Workers, 2021).
This study has several implications for research-informed social work practice. Research
findings on the predictive value of psychosocial factors on HCT outcomes are mixed and
do not support patients being excluded from HCT based on psychosocial factors. This
suggests the need for caution about how psychosocial assessment results are used in
determining a patient’s eligibility for transplant. It also suggests a need for ongoing
conversation about stigma related to psychosocial factors and how bias may underlie
eligibility decisions. As Richardson, Devine, et al. (2018) candidly acknowledged, “we
are concerned that perhaps providers hesitate to enroll patients with psychosocial risk
factors because, consciously or subconsciously, we may simply not like taking care of
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them” (p. 1427). The role of implicit bias in clinical decision-making has been
documented (Garb, 2013), and social workers are not immune to this.
Program Policy
The psychosocial domain is vitally important for the HCT process. Much funding
goes towards advancing medical research and technology. Unfortunately, this technology
is useless if patients do not have the capacity to endure the treatment. Said another way,
optimizing the technology without optimizing the patient is short-sighted. Providing the
best care for patients means focusing on them, promoting their capacity, not just
advancing the medical technology they receive. Financial resources need to be allocated
so that patients can get to and through HCT. Additionally, all patients should be assessed
and provided subsequent care to bolster their capacity. Unfortunately, evidence shows
that at some transplant centers, not all patients are assessed (Randall et al., 2021).
The results of this study in conjunction with the literature on caregivers’
experience and outcomes suggests that going through HCT is as arduous for them as for
the patient. There are well-known risks to their health and well-being. Ethically, this
raises the question of whether a more formalized informed consent process should be
implemented for the caregiver. If so, what information do they need about the risks?
Adding further complexity to the situation, most patients have few caregiver options.
Thus, the caregiver is under pressure to assume the role because the patient may not be
able to move forward with HCT without them.
The mixed findings of the effect of psychosocial high risk factors on outcomes do
not support excluding patients from transplant based on psychosocial factors unless there
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is a clear indication of imminent harm. Also, psychosocial eligibility policies seem
premature and should be revisited by transplant programs that use them.
Workforce Training
Consistent with the concept mapping emphasis on valuing voice, opportunities
exist to continue elevating the voices of psychosocial professionals in HCT by presenting
the conceptual framework and resulting assessment protocol at professional conferences
and to interdisciplinary teams. The conceptual framework may be used to educate social
workers and psychologists new to HCT. This would be particularly valuable at smaller
centers where turnover may result in no training for the incoming social worker. Finally,
education for all members of the HCT team about the state of the evidence linking
psychosocial factors to outcomes is warranted. Without education on this, professionals
might harbor misunderstandings about this relationship. As Richardson, Devine, et al.
(2018) remarked, “practically there remains little doubt among HCT providers that
patients who continue to abuse substances do worse with HCT” (p. 1475). This thinking,
which is not supported by evidence, influences clinical decision-making and could have
serious consequences for the patient’s type and quality of care.
Research
Concept mapping has not been used before in HCT. In recent years, increasing
emphasis has been placed on participatory research with funding sources requiring that
projects be guided by patients, caregivers, and community stakeholders (Patient Centered
Outcomes Research Institute, 2021). Concept mapping methodology would bring this
participatory component and could help clarify ambiguous concepts. “Barriers” is one of
these concepts. Concept mapping studies have elucidated the meaning of barriers in
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various contexts (Ahmad et al., 2012; Daoud et al., 2018). Given its high importance and
potential for greater conceptual clarity, a concept mapping study to conceptualize barriers
in the context of HCT is warranted.
The literature contains factors that researchers and clinicians think are important
for undergoing HCT, but the voices of patients and caregivers have largely not been
heard. A concept mapping study could help define and conceptualize what patients and
caregivers perceive helped them and hindered them during the HCT process. Their ideas
and thinking could reveal dimensions that have not been considered by researchers and
clinicians.
The literature would benefit from some delineation of the most salient
psychosocial factors and outcomes that need to be investigated with prospective, multicenter studies. The statements in the Go-Zones from the highest rated clusters suggest
what these might be. From the Mental Health cluster, these include mental health and
substance use, both of which are present in the literature but could benefit from more
rigorous measurement and new investigation. From the Transplant Mindset cluster, these
include adjustment to illness, coping strategies, coping style, and adherence. From the
Caregiver cluster, these include the caregiver’s understanding of the transplant process,
the caregiver’s functional limitations, substance use, mental health, and ability to perform
required tasks. These variables have not been examined in the literature.
The literature has described caregivers’ experience and outcomes from primarily a
quantitative perspective. Qualitative research could make significant contributions and
should be conducted. Specifically, a phenomenological study could provide a rich
description of the lived experience and common meaning of going through HCT as a
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caregiver. This rich description of the essence of the caregiving experience is a gap in the
literature, that if filled, could suggest novel interventions to support this population.
Another area for investigation is to understand how patients and caregivers define
“success” in HCT. What constitutes a successful experience and outcome for them?
Concept mapping methodology could help answer this question.
Study Strengths
This study fills a gap and addresses limitations in the literature. As previously
discussed, the literature that conceptualizes the psychosocial elements that should be
assessed in HCT candidates is extremely limited. The field of HCT has mostly relied on
conceptualizations of psychosocial risk factors produced in the context of solid organ
transplantation. This study fills that gap by providing a conceptualization specific to HCT
that encompasses all factors, not just those thought to contribute to risk.
Conceptualizations were produced primarily based on literature review and the
clinical experience of a few people, most of whose roles do not include performing
psychosocial assessments. Concept mapping methodology addresses these limitations. It
offers a more rigorous method of conceptualization as outlined in Chapter 3. Its mixedmethods approach elicits the perspectives of many individuals who regularly assess HCT
candidates. Previously, their voices had not been heard. Lastly, the data and conceptual
framework generated by this study are action-oriented. They may be used to inform
practice changes that would move the field forward.
Study Limitations
No study is without limitations. One limitation of this study is the way in which
power was conceptualized. While positioned lower in the health care hierarchy relative to
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other disciplines, social workers still have power related to being members of the health
care system. In HCT, they serve a gatekeeping function in that their interpretation of the
patient’s psychosocial risk can impact the patient’s access to transplant. In this study, the
participants identified primarily as non-Hispanic white, which also positions them as
having more power. This may have influenced the elements they choose to assess and the
priority they give to those elements. The lack of racial/ethnic diversity in the sample
likely accurately reflects the field, as previous study results (Stickney Ferguson et al.,
2018) have also shown minimal diversity in this professional population. This lack of
diversity reflects a structural problem. Future research can address this limitation by
purposively sampling racially and ethnically diverse participants.
There are several limitations related to the reliability and validity of concept
mapping methodology. Concept mapping studies are highly contextual; thus the
reliability and validity of the data can be difficult to assess (Miller, 2016). In concept
mapping, validity refers to “the degree to which a map accurately reflects reality”
(Trochim, 1989, p. 106). Validity can be discussed in terms of internal validity and
external validity. Internal validity refers to the research process itself, the coherence of
the design components and ability to answer the research question (Panke, 2018). In this
study, internal validity was strengthened through adherence to the concept mapping
process as outlined in foundational texts and by ongoing consultation with a committee
member who has expertise in the methodology.
According to Creswell and Poth (2018) the validity of qualitative data is best
assessed by the researcher, participants, and readers/reviewers. Validity, or validation, in
this sense is a process of evaluating the trustworthiness or authenticity of the data.
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(Creswell & Poth, 2018). Several strategies support the validation of the qualitative data.
The statement editing process contributed to the trustworthiness of the data by clarifying
wording and meaning. The congruence of the qualitative data with topics and themes in
the literature is also evidence of trustworthiness. The oral defense of this dissertation will
also check validity and the researcher’s scientific interpretation before being presented to
participants.
In terms of the validity of the statistical processes, multidimensional scaling and
hierarchical cluster analysis allow “meaning and relationships to emerge by aggregating
the ‘biases’ or ‘constructions’ of many” (Jackson & Trochim, 2002, p. 330). Instead of
forcing the participants to sort according to a priori categories that could be influenced by
the researcher’s bias, concept mapping allows them to sort based on the meanings they
have based on their social realities (Jackson & Trochim, 2002). Given the researcher’s
experience assessing HCT candidates, this aspect of the method was helpful for reducing
bias. Another strategy for assessing validity is to compare the number of piles individuals
created with the final cluster solution. In this study, the mode number of piles was 13,
which is very close to the final 12-cluster solution. This suggests that the cluster solution
is an adequate representation of group’s aggregate mental model.
External validity refers to the generalization of the findings. The number of
participants poses a challenge for external validity. It is unknown how many social
workers and psychologists work within HCT programs in the U.S., but there are
approximately 143 transplant centers and each would have at least one psychosocial
professional. The perspectives represented in this study, then, are of a relatively small
percentage of the total number of psychosocial professionals and would not be
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generalizable to the entire population. The lack of diversity in the sample also poses a
challenge to external validity. The vast majority of the sample identified as non-Hispanic
white, female, social workers. It is possible that professionals of color, males, and
psychologists would have different perspectives on what psychosocial elements should be
assessed, the relational structure of those elements, and their importance. Therefore, the
conceptual framework may not adequately incorporate those perspectives.
In concept mapping, reliability refers to replicability and requires close attention
to each stage of the multi-stage research process (Miller, 2016; Trochim, 1989a). As
mentioned above, reliability was supported by following the concept mapping process as
outlined in foundational texts and by ongoing consultation with a committee member
who has expertise in the methodology. One way to test reliability would be to ask the
same participants to sort and rate the statements in the future and compare the maps and
data (Jackson & Trochim, 2002). Additionally, the brainstorming phase could be repeated
and final statement sets compared.

Conclusions
The purpose of this study was to explicate a conceptual framework of the
psychosocial elements that should be assessed in HCT candidates and to test if there is a
difference in the way psychosocial professionals who use risk rating scales their practice
conceptualize the elements compared to psychosocial professionals who do not. The
study effectively answered these questions.
The use of concept mapping successfully ensured that the breadth of the topic was
explored and revealed different dimensions of the conceptual domain. The resulting
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conceptual framework provides a strong starting point for practical action. The cluster
solution suggests a structure for organizing a comprehensive pre-HCT psychosocial
assessment protocol. It also suggests priority areas for assessment. Most importantly, the
participants in this study will carry on the work of creating a protocol. This is their work,
which the researcher has been privileged to facilitate. If tested and then implemented
broadly, the protocol will bring a high quality, consistent standard for social work practice
in this area.
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APPENDIX A: PARTICIPANT QUESTIONNAIRE

Please tell us about yourself, your professional perspectives, and your center.

1. What is your professional role?
a. Social Worker
b. Psychologist
2. How many years of practice experience do you have with HCT patients?
3. What, if any, standardized risk assessment tool do you use?
a. SIPAT
b. PACT
c. TERS
d. None of the above
4. What is your age?
5. What is your race/ethnicity?
a. Non-Hispanic White
b. African American or Black
c. Asian
d. Hispanic/Latino/Latina
e. American Indian or Alaska Native
f. Native Hawaiian or Other Pacific Islander
g. Multiple Race
6. How often do you have the time you need to complete a quality pre-transplant
psychosocial assessment? (Likert scale: Always, Most of the time, About half the
time, Sometimes, Never)
7. How often do you have the time you need to adequately address needs that are
identified in the pre-transplant psychosocial assessment? (Likert scale: Always,
Most of the time, About half the time, Sometimes, Never)
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8. In your view, how do the following risk factors compare to one another? Please
rank all of the factors according to the amount of risk they pose for a poor
outcome. Use the drag and drop feature to order them from 1-6 with 1
representing the highest risk and 6 representing the lowest risk.

a.
b.
c.
d.
e.
f.

No caregiver / poor support system
Compliance issues
Illicit drug use
Alcohol misuse
Unsafe, unstable housing
Serious, untreated mental health issues

9. What has helped shape your view about factors that pose a risk for a poor
transplant outcome? (Multi-line text entry)
10. At your center, how often are psychosocial risk factors considered when deciding
whether a patient is eligible for a transplant? (Likert scale: Always, Most of the
time, About half the time, Sometimes, Never)
11. In terms of practice setting, which best describes your experience with transplant
patients? (Select one)
a. Only outpatient
b. Only inpatient
c. Both outpatient and inpatient
12. Approximately how many pre-transplant psychosocial assessments do you
conduct in a typical week?
a. Less than 1
b. 1
c. 2
d. 3
e. More than 3
13. What treatments do the patients that you assess undergo? (Check all that apply)
a. Autologous transplant
b. Allogeneic transplant
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c. CAR T-cell therapy
14. What treatments does your center offer? (Check all that apply)
a. Autologous transplant
b. Allogeneic transplant
c. CAR T-cell therapy
15. Which, if any, professional associations are you currently a member of? (Check
all that apply)
a. AOSW
b. APOS
c. IPOS
d. ASTCT
e. NASW
f. Other, please specify:______________________________
g. I am not currently a member of any professional association.
16. What is the highest degree you have earned? Bachelor’s degree___ Master’s
degree___ DSW___ PsyD___ Ph.D.___
17. How would you describe your gender? Female ___ Male ___ Transgender ___
18. What is the geographic region of your center?

a.
b.
c.
d.
e.

Northeast
Southeast
Midwest
West
Southwest

19. Is there anything else you would like to share with the researchers about your
experience working in HCT?
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Journal of Psychosocial Oncology Editorial Board
Association of Oncology Social Work Membership Committee
Be The Match Barriers to Transplant Advisory Group
Reviewer for the Journal of Psychosocial Oncology
Be The Match Patient Services Advisory Group
BMT InfoNet Support Group Facilitator
Association of Oncology Social Work Conference Planning Committee
Courier of hematopoietic cells from donor to patient

2021 – present
2021 – present
2020 – present
2020 – present
2017 – present
2018 – 2020
2017, 2020
2016 – 2017
2015 – 2016

PROFESSIONAL SOCIETIES AND LICENSURE
American Psychosocial Oncology Society
Society for Social Work Research
American Society for Transplantation and Cellular Therapy
Association of Oncology Social Work
Licensed Independent Clinical Social Worker, MN Board of Social Work
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2018 – present
2012 – present
2012 – present
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1. Randall, J. (2020). Psychosocial eligibility for hematopoietic cell transplantation.
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the Transplantation and Cellular Therapy meetings. Orlando, FL.
2. Randall, J. (2017). Caregivers: Facing Challenges and Forging Resilience. Podium
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3. Carpenter, P. A. & Randall, J. (2016). Coping with chronic GVHD of the skin and
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sponsored by the National Marrow Donor Program.
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J. (2015). Caring for the psychosocial health needs of BMT caregivers. Podium
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6. Randall, J. & Leary, E. (2012). Keynote speakers on the topic of stress management
at the Multiple Myeloma Patient and Caregiver Seminar presented by the Leukemia
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